"Molecule ChEMBL ID";"Molecule Name";"Molecule Max Phase";"Molecular Weight";"#RO5 Violations";"AlogP";"Compound Key";"Smiles";"Standard Type";"Standard Relation";"Standard Value";"Standard Units";"pChEMBL Value";"Data Validity Comment";"Comment";"Uo Units";"Ligand Efficiency BEI";"Ligand Efficiency LE";"Ligand Efficiency LLE";"Ligand Efficiency SEI";"Potential Duplicate";"Assay ChEMBL ID";"Assay Description";"Assay Type";"BAO Format ID";"BAO Label";"Assay Organism";"Assay Tissue ChEMBL ID";"Assay Tissue Name";"Assay Cell Type";"Assay Subcellular Fraction";"Assay Parameters";"Assay Variant Accession";"Assay Variant Mutation";"Target ChEMBL ID";"Target Name";"Target Organism";"Target Type";"Document ChEMBL ID";"Source ID";"Source Description";"Document Journal";"Document Year";"Cell ChEMBL ID";"Properties";"Action Type";"Standard Text Value"
"CHEMBL5086498";"";"None";"522.43";"1";"3.68";"544";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(C(F)(F)C(=O)O)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"12.48";"0.24";"2.84";"6.69";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5075894";"";"None";"578.56";"2";"5.25";"565";"CN1CC2CCC1CN2c1cc2c(c(C(F)(F)F)c1)CN(c1cccc([C@@](C)(F)C(F)(F)c3nncn3C)c1)C2=O";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5077680";"";"None";"389.42";"0";"1.62";"605";"Cn1cnnc1CC1(c2cccc(NC(=O)c3ccnc4ccnn34)c2)COC1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"17.98";"0.33";"5.38";"7.05";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088577";"";"None";"554.62";"1";"3.64";"624";"CCN1CCN(Cc2cc3c(c(C(F)(F)F)c2)CN(c2cccc(C4(Cc5nncn5C)COC4)c2)C3=O)CC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082004";"";"None";"560.58";"1";"4.42";"660";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5Cc6cccnc6C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5092391";"";"None";"440.45";"0";"3.10";"676";"Cc1cc(C(=O)Nc2cccc(C3(C(F)(F)c4nncn4C)COC3)c2)nc(C2CC2)n1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079870";"";"None";"561.56";"1";"4.74";"693";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCCC(F)(F)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091435";"";"None";"443.51";"0";"2.79";"236";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CC[C@H](C#N)C3)ccn2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"13.53";"0.25";"3.21";"5.14";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5072501";"";"None";"430.43";"0";"4.31";"291";"CCOC(Cc1nncn1C)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"12.83";"0.24";"1.21";"9.17";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093648";"";"None";"350.43";"0";"2.63";"313";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2n[nH]c3c2CCC3)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"19.98";"0.37";"4.37";"7.91";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5075576";"";"None";"379.34";"0";"3.42";"315";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2coc(C(F)(F)F)n2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"17.19";"0.33";"3.10";"7.60";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086153";"";"None";"429.45";"0";"4.70";"322";"C[C@@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C3CC3)cc(C(F)(F)F)n2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"15.19";"0.29";"1.82";"8.97";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082851";"";"None";"399.38";"0";"3.66";"369";"Cn1cnnc1[C@@H]1C[C@@H]1c1cccc(N2Cc3c(ccnc3C(F)(F)F)C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"16.33";"0.31";"2.86";"10.20";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079169";"";"None";"415.54";"0";"4.18";"376";"CNCc1ccc(C(=O)Nc2cccc([C@H]3[C@H](C)[C@H]3c3nncn3C)c2)cc1C1CC1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"16.85";"0.31";"2.82";"9.74";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5085400";"";"None";"484.53";"0";"4.11";"379";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc(N[C@H]4CCNC4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5072561";"";"None";"571.62";"2";"5.39";"553a";"C[C@@H](c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O)N1CCC(C)(F)CC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5081592";"";"None";"513.65";"1";"3.79";"592b";"C[C@H](c1cc(C(=O)Nc2cccc(C3(Cc4nncn4C)COC3)c2)nc(C2CC2)n1)N1CCC2(CC2)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5087619";"";"None";"582.63";"1";"3.07";"713";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CC[C@@H]6NCCO[C@@H]6C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079495";"";"None";"567.61";"1";"4.12";"718";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCOC(C6CC6)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086494";"";"None";"478.50";"0";"3.65";"174";"CC(Sc1nncn1C)c1cc(NCCO)nc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"12.54";"0.25";"2.35";"6.24";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5081195";"";"None";"448.47";"0";"4.28";"180";"CNc1cc(C(C)Sc2nncn2C)cc(N2Cc3c(cccc3C(F)(F)F)C2=O)n1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"13.38";"0.26";"1.72";"7.90";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093222";"";"None";"389.38";"0";"3.83";"183b";"C[C@@H](Cc1nncn1C)c1cccc(NC(=O)c2cccc(C(F)(F)F)n2)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"17.98";"0.34";"3.17";"9.63";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079950";"";"None";"374.49";"0";"4.60";"331";"Cc1ccc(C(=O)Nc2cccc(C(C)Cc3nccn3C)c2)nc1C1CC1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"16.02";"0.29";"1.40";"10.03";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5071331";"";"None";"400.40";"0";"4.34";"263";"C[C@H](Cc1ncn(C)n1)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"13.79";"0.26";"1.18";"10.82";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080753";"";"None";"378.36";"0";"3.16";"326";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2nc(C(F)(F)F)c[nH]2)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"18.50";"0.35";"3.84";"7.91";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079950";"";"None";"374.49";"0";"4.60";"331";"Cc1ccc(C(=O)Nc2cccc(C(C)Cc3nccn3C)c2)nc1C1CC1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"17.41";"0.32";"1.92";"10.90";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088973";"";"None";"426.40";"0";"4.23";"332";"Cn1cnnc1[C@@H]1C[C@@H]1c1cccc(NC(=O)c2nc3c(C(F)(F)F)cccc3[nH]2)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"16.42";"0.31";"2.77";"7.91";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5085578";"";"None";"432.41";"0";"2.70";"338";"Cc1cc(C(=O)Nc2cccc(C3(Cc4nncn4C)COC3)c2)nc(C(F)(F)F)n1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5090163";"";"None";"367.48";"0";"3.96";"47";"CNc1cccc(C(=O)Nc2cccc([C@H](C)Sc3nncn3C)c2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"15.03";"0.29";"1.56";"7.69";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088592";"";"None";"422.44";"0";"3.92";"49";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2nc(C(F)(F)F)ccc2N)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"14.20";"0.28";"2.08";"6.08";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083702";"";"None";"411.92";"1";"5.06";"78";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc3c(Cl)cccc3[nH]2)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"16.99";"0.34";"1.94";"9.26";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5070292";"";"None";"425.41";"0";"4.47";"95a";"C[C@H](Sc1nncn1C)c1ccc(F)c(NC(=O)c2cccc(C(F)(F)F)n2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"15.33";"0.31";"2.05";"8.97";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076641";"";"None";"408.41";"0";"3.73";"102b";"C[C@H](Sc1nncn1C)c1ccnc(NC(=O)c2cccc(C(F)(F)F)n2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"14.69";"0.29";"2.27";"7.01";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079013";"";"None";"394.50";"0";"3.59";"109";"C[C@H](Sc1nncn1C)c1ccnc(NC(=O)c2cc3c(cn2)CCCC3)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"14.00";"0.27";"1.93";"6.45";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083777";"";"None";"390.47";"0";"3.86";"112";"C[C@H](Sc1nncn1C)c1ccnc(NC(=O)c2ccc3ccccc3n2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"16.70";"0.32";"2.66";"7.62";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080261";"";"None";"389.48";"0";"4.77";"128a";"Cc1c[nH]nc1S[C@@H](C)c1ccnc(NC(=O)c2ccc3ccccc3n2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"15.40";"0.29";"1.23";"7.18";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086069";"";"None";"462.46";"0";"4.78";"130a";"Cc1nc2cc([C@H](C)Sc3nncn3C)cc(NC(=O)c3cccc(C(F)(F)F)n3)c2o1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"14.10";"0.28";"1.74";"6.61";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5085985";"";"None";"479.61";"0";"3.09";"160";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CC[C@H](N(C)C)C3)ccn2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"11.52";"0.22";"2.43";"5.74";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091892";"";"None";"436.43";"0";"4.99";"170";"C[C@@H](Sc1nncn1C)c1ccc(F)c(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"";""
"CHEMBL5085525";"";"None";"419.43";"0";"4.24";"172a";"C[C@H](Sc1nncn1C)c1ccnc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"15.55";"0.31";"2.28";"10.20";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5092337";"";"None";"399.48";"0";"2.21";"185";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cccc(S(C)(=O)=O)n2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"16.32";"0.32";"4.31";"6.10";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091738";"";"None";"390.37";"0";"3.22";"187";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2ccnc(C(F)(F)F)n2)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"17.93";"0.34";"3.78";"8.18";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079524";"";"None";"390.37";"0";"3.22";"189";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cncc(C(F)(F)F)n2)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"17.93";"0.34";"3.78";"8.18";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089341";"";"None";"597.60";"0";"3.24";"209";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc3cc(N4CCN(C)C(=O)C4)ccc3cn2)c1.O=C(O)C(F)(F)F";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080479";"";"None";"611.62";"0";"3.63";"211";"CC(=O)N1CCN(c2ccc3cnc(C(=O)Nc4cccc([C@H](C)Cc5nncn5C)c4)cc3c2)CC1.O=C(O)C(F)(F)F";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079380";"";"None";"388.39";"0";"4.66";"215";"Cc1ccnn1CC(C)c1cccc(NC(=O)c2cccc(C(F)(F)F)n2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"16.79";"0.32";"1.86";"10.90";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5084081";"";"None";"482.57";"0";"1.68";"225";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CC(S(C)(=O)=O)C3)ccn2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"12.43";"0.24";"4.32";"4.72";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088625";"";"None";"433.51";"0";"2.62";"252";"CC(Cc1nccn1C)c1cccc(NC(=O)c2cc(C(=O)N3CC[C@H](O)C3)ccn2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"12.74";"0.24";"2.90";"5.50";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076824";"";"None";"485.59";"0";"3.41";"277";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc(C(=O)N4CC[C@H](O)C4)cc3C3CC3)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5072881";"";"None";"364.45";"0";"3.19";"323";"CC1CCc2c1n[nH]c2C(=O)Nc1cccc([C@H](C)Cc2nncn2C)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"19.21";"0.35";"3.81";"7.91";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5090578";"";"None";"548.49";"1";"4.93";"456";"Cn1cnnc1C(F)(F)[C@](C)(F)c1cccc(N2Cc3c(cc(CN4CC(C#N)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"12.76";"0.25";"2.07";"8.97";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091957";"";"None";"615.60";"1";"4.59";"457";"Cn1cnnc1C(F)(F)[C@](C)(F)c1cccc(N2Cc3c(cc(CN4CC[C@H](S(C)(=O)=O)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091339";"";"None";"549.52";"2";"5.36";"462";"Cn1cnnc1C(F)(F)C1(c2cccc(N3Cc4c(cc(CN5CC[C@H](F)C5)cc4C(F)(F)F)C3=O)c2)CC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5081345";"";"None";"466.47";"0";"4.53";"384";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc(-n4cccn4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5094793";"";"None";"485.51";"0";"3.52";"393";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc(CN4CC(O)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083467";"";"None";"513.52";"1";"4.72";"407";"Cc1conc1C[C@@H](C)c1cccc(N2Cc3c(cc(C(=O)N4CC[C@H](O)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088905";"";"None";"481.43";"0";"4.38";"356";"C[C@H](Cc1nncn1C)c1cc(OCC(F)F)nc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5092676";"";"None";"400.40";"1";"5.51";"367b";"Cc1conc1C[C@H](C)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"14.98";"0.28";"0.49";"12.95";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088937";"";"None";"400.40";"1";"5.51";"367a";"Cc1conc1C[C@@H](C)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"17.48";"0.33";"1.49";"15.11";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093434";"";"None";"407.42";"0";"4.33";"32";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C(F)(F)F)ccn2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"13.56";"0.27";"1.19";"7.60";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078650";"";"None";"389.48";"0";"4.47";"9";"CC(Sc1nncn1C)c1cccc(NC(=O)c2ccc3ccccc3n2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"16.74";"0.32";"2.05";"8.97";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5077526";"";"None";"424.42";"1";"5.08";"42";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cccc(C(F)(F)F)c2F)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"15.37";"0.31";"1.44";"10.90";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5084543";"";"None";"441.87";"0";"4.99";"66";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C(F)(F)F)cc(Cl)n2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"13.58";"0.28";"1.01";"8.25";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083317";"";"None";"403.46";"0";"4.43";"81";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cccc(C(C)(F)F)n2)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"17.35";"0.34";"2.57";"9.63";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091709";"";"None";"415.52";"1";"5.27";"99";"C[C@H](Sc1nncn1C1CC1)c1cccc(NC(=O)c2cc3ccccc3cn2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"15.69";"0.30";"1.25";"8.97";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093962";"";"None";"436.54";"0";"3.55";"138";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CCCC3)ccn2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"12.65";"0.24";"1.97";"5.94";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083783";"";"None";"440.53";"0";"2.43";"157";"C[C@H](O)CNC(=O)c1ccnc(C(=O)Nc2cccc([C@H](C)Sc3nncn3C)c2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"12.54";"0.24";"3.09";"4.53";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5084009";"";"None";"479.61";"0";"3.09";"159";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CC[C@@H](N(C)C)C3)ccn2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"11.52";"0.22";"2.43";"5.74";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088347";"";"None";"452.54";"0";"2.52";"161";"C[C@@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CC[C@@H](O)C3)ccn2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"12.20";"0.24";"3.00";"4.88";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079311";"";"None";"404.40";"0";"3.53";"194";"Cc1cc(C(=O)Nc2cccc([C@H](C)Cc3nncn3C)c2)nc(C(F)(F)F)n1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5084647";"";"None";"376.46";"0";"3.39";"195";"Cc1cc(C(=O)Nc2cccc([C@H](C)Cc3nncn3C)c2)nc(C2CC2)n1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086818";"";"None";"420.52";"0";"3.13";"208";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(N[C@H]3CC[C@@H](O)C3)ccn2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"15.51";"0.29";"3.39";"6.21";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5070829";"";"None";"418.39";"0";"4.48";"280";"C[C@H](Cc1nncn1C)c1cc(N2Cc3c(cccc3C(F)(F)F)C2=O)ccc1F";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"13.20";"0.25";"1.04";"10.82";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080552";"";"None";"412.42";"0";"4.66";"283";"Cn1cnnc1[C@H]1CC[C@H]1c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"15.81";"0.30";"1.86";"12.78";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5092831";"";"None";"418.38";"0";"2.76";"292";"Cn1cnnc1[C@H](O)[C@@H](O)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"14.34";"0.27";"3.24";"6.56";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086040";"";"None";"476.56";"0";"3.59";"306a";"CNC(=O)COc1ccc2cnc(C(=O)Nc3cccc([C@H](C)Sc4nncn4C)c3)cc2c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"14.69";"0.28";"3.41";"6.30";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079292";"";"None";"468.54";"0";"1.49";"155";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3C[C@H](O)[C@@H](O)C3)ccn2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"12.80";"0.25";"4.51";"4.50";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5071863";"";"None";"514.63";"1";"2.57";"158";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CCC(S(C)(=O)=O)C3)ccn2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"10.73";"0.22";"2.95";"4.34";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5073611";"";"None";"436.43";"0";"4.99";"169";"C[C@H](Sc1nncn1C)c1ccc(F)c(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"13.75";"0.27";"1.01";"11.76";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082645";"";"None";"462.50";"0";"4.67";"178";"CCNc1cc(C(C)Sc2nncn2C)cc(N2Cc3c(cccc3C(F)(F)F)C2=O)n1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"14.10";"0.28";"1.85";"8.59";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080720";"";"None";"371.44";"0";"3.96";"182";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc3ccccc3cn2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"17.56";"0.32";"2.56";"8.97";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5087133";"";"None";"389.38";"0";"3.83";"183a";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cccc(C(F)(F)F)n2)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091941";"";"None";"419.41";"0";"3.84";"192";"COc1cc(C(=O)Nc2cccc([C@H](C)Cc3nncn3C)c2)nc(C(F)(F)F)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"15.55";"0.30";"2.68";"7.96";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5090435";"";"None";"369.45";"0";"3.32";"38";"COc1cccc(C(=O)Nc2cccc([C@H](C)Sc3nncn3C)c2)n1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"17.65";"0.34";"3.20";"7.96";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079015";"";"None";"359.48";"0";"3.69";"41";"Cc1nc(C(=O)Nc2cccc([C@H](C)Sc3nncn3C)c2)cs1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"16.69";"0.34";"2.31";"8.25";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078016";"";"None";"421.45";"0";"4.64";"52";"Cc1cnc(C(=O)Nc2cccc([C@H](C)Sc3nncn3C)c2)cc1C(F)(F)F";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"13.10";"0.26";"0.88";"7.60";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5070504";"";"None";"413.45";"0";"4.40";"74";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2nc(C(F)(F)F)cs2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"15.77";"0.33";"2.12";"8.97";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5084910";"";"None";"465.50";"0";"4.56";"85";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C(C)(C)O)cc(C(F)(F)F)n2)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"15.04";"0.30";"2.44";"7.53";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5070319";"";"None";"425.41";"0";"4.47";"95b";"C[C@@H](Sc1nncn1C)c1ccc(F)c(NC(=O)c2cccc(C(F)(F)F)n2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"12.98";"0.26";"1.05";"7.60";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078541";"";"None";"408.41";"0";"3.73";"127";"CC(Sc1nncn1C)c1cncc(NC(=O)c2cccc(C(F)(F)F)n2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"13.52";"0.27";"1.79";"6.45";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093430";"";"None";"468.46";"0";"2.47";"200";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(S(N)(=O)=O)cc(C(F)(F)F)n2)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"14.94";"0.30";"4.53";"5.27";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5073682";"";"None";"482.49";"0";"2.74";"201";"CNS(=O)(=O)c1cc(C(=O)Nc2cccc([C@H](C)Cc3nncn3C)c2)nc(C(F)(F)F)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"14.51";"0.29";"4.26";"5.89";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088527";"";"None";"386.38";"0";"4.33";"262";"C[C@H](Cc1nnc[nH]1)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"16.88";"0.32";"2.19";"10.54";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5071050";"";"None";"573.59";"1";"4.07";"521";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCOC(CCF)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5092777";"";"None";"417.47";"0";"2.24";"606";"Cc1cc(C(=O)Nc2cccc(C3(Cc4nncn4C)COC3)c2)n2ncc(C)c2n1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5085997";"";"None";"496.49";"0";"3.92";"612";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(C5=CCOC5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5084921";"";"None";"587.59";"2";"5.13";"636";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCC6(CC6)C(F)(F)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082147";"";"None";"555.60";"1";"4.12";"637";"COC1CCCN(Cc2cc3c(c(C(F)(F)F)c2)CN(c2cccc(C4(Cc5nncn5C)COC4)c2)C3=O)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5081895";"";"None";"591.58";"1";"3.95";"644a";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CC[C@@H](CO)C(F)(F)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5071911";"";"None";"603.65";"2";"5.07";"661";"COc1ccc2c(c1)CN(Cc1cc3c(c(C(F)(F)F)c1)CN(c1cccc(C4(Cc5nncn5C)COC4)c1)C3=O)CC2";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083064";"";"None";"467.45";"0";"4.13";"684";"C[C@H](Cc1nncn1C)c1cc(-c2cn[nH]c2)nc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"13.95";"0.26";"2.39";"7.04";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089254";"";"None";"402.50";"0";"3.71";"694";"Cc1cc(C(=O)Nc2cccc(C3(Cc4nncn4C)CCC3)c2)nc(C2CC2)n1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083081";"";"None";"535.61";"2";"5.64";"695";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCC6(CC6)C5)cc4C(F)(F)F)C3=O)c2)CCC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080848";"";"None";"429.40";"0";"2.90";"696";"Cn1cnnc1CC1(c2cccc(N3Cc4c(ccnc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079775";"";"None";"534.54";"1";"4.59";"697";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(C(O)c5ccccc5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089758";"";"None";"551.61";"2";"5.02";"556";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5C6CCCC5CC6)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076947";"";"None";"564.53";"1";"4.86";"566";"CN1CC2CC(C1)N2c1cc2c(c(C(F)(F)F)c1)CN(c1cccc([C@@](C)(F)C(F)(F)c3nncn3C)c1)C2=O";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079747";"";"None";"487.61";"0";"3.23";"589";"Cn1cnnc1CC1(c2cccc(NC(=O)c3cc(CN4CCCCC4)nc(C4CC4)n3)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5084157";"";"None";"454.37";"0";"4.97";"296a";"Cn1cnnc1C(F)(F)[C@](C)(F)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"15.41";"0.30";"2.03";"13.72";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5075049";"";"None";"376.46";"0";"3.39";"325";"Cc1cc(C(=O)Nc2cccc([C@@H](C)Cc3nncn3C)c2)nc(C2CC2)n1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"18.59";"0.34";"3.61";"8.18";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5069885";"";"None";"473.46";"0";"3.51";"354";"C[C@H](Cc1nncn1C)c1cc(OC2COC2)nc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"14.78";"0.28";"3.49";"8.50";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080290";"";"None";"515.56";"2";"5.45";"403";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc([C@@H](C)N4CC[C@H](F)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079514";"";"None";"536.56";"1";"3.85";"421";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CC[C@@H](C#N)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080725";"";"None";"527.55";"1";"3.34";"431";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCOCC5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5090613";"";"None";"400.49";"0";"4.14";"518";"Cc1cc(C(=O)Nc2cccc(C3=C(c4nncn4C)CCC3)c2)nc(C2CC2)n1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"17.48";"0.32";"2.86";"8.18";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5084132";"";"None";"522.53";"1";"4.31";"542";"CC(c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O)n1ccnc1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091446";"";"None";"593.57";"2";"5.28";"588";"CC1C(C(F)(F)F)CCN1Cc1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5085551";"";"None";"476.45";"1";"5.77";"482";"Cn1cnnc1[C@H](F)[C@@](C)(F)c1cccc(N2Cc3c(cc(C4CC4)cc3C(F)(F)F)C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"13.69";"0.26";"0.75";"12.78";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5081160";"";"None";"569.48";"2";"6.40";"485";"C[C@H](Cc1nocc1C(F)(F)F)c1cccc(N2Cc3c(cc(C(=O)N4CC[C@H](F)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"12.29";"0.24";"0.60";"10.50";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080930";"";"None";"570.51";"1";"4.72";"550";"CN(c1cc2c(c(C(F)(F)F)c1)CN(c1cccc([C@@](C)(F)C(F)(F)c3nncn3C)c1)C2=O)[C@H]1CNC[C@@H]1F";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086032";"";"None";"543.57";"1";"4.96";"674a";"Cn1cnnc1[C@@H](F)C1(c2cccc(N3Cc4c(cc(CN5CCCCC5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5092742";"";"None";"587.62";"2";"5.01";"691a";"CCOc1cc(N2Cc3c(cc([C@@H](C)N4CC[C@H](F)C4)cc3C(F)(F)F)C2=O)cc(C2(Cc3nncn3C)COC2)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5075841";"";"None";"462.55";"0";"2.80";"227";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CCC(C)(O)CC3)ccn2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"12.97";"0.24";"3.20";"5.30";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5094154";"";"None";"387.36";"0";"4.60";"266";"C[C@H](Cc1nnco1)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"14.26";"0.27";"0.92";"9.32";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076151";"";"None";"399.42";"0";"4.95";"267a";"C[C@H](Cc1nccn1C)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"15.02";"0.28";"1.05";"15.73";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5090348";"";"None";"641.57";"1";"3.94";"275";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc(C(=O)N4C[C@@H](O)C[C@H]4C)cc3C(F)(F)F)C2=O)c1.O=C(O)C(F)(F)F";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093470";"";"None";"418.50";"0";"2.94";"340";"Cc1cc(C(=O)Nc2cccc(C3(Cc4nncn4C)COC3)c2)nc(C2CCC2)n1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083927";"";"None";"444.46";"0";"4.17";"360";"CCNc1cc([C@H](C)Cc2nncn2C)cc(N2Cc3c(cccc3C(F)(F)F)C2=O)n1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5081892";"";"None";"486.50";"0";"3.94";"361";"C[C@H](Cc1nncn1C)c1cc(N[C@H]2CCOC2)nc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"13.40";"0.25";"2.58";"7.66";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5074307";"";"None";"562.52";"2";"5.32";"455";"Cn1cnnc1C(F)(F)[C@](C)(F)c1cccc(N2Cc3c(cc(CN4CC[C@@H](C#N)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079797";"";"None";"526.56";"2";"5.03";"464";"CC1C=NN=C1C[C@@H](C)c1cccc(N2Cc3c(cc(C(=O)N4C[C@@H](O)C[C@H]4C)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5087734";"";"None";"436.38";"0";"4.89";"467";"C[C@@H](c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1)C(F)(F)c1nncn1C";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"16.04";"0.31";"2.11";"13.72";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5090140";"";"None";"456.47";"0";"3.88";"470";"Cn1cnnc1C[C@]1(c2cccc(N3Cc4c(cccc4C(F)(F)F)C3=O)c2)C[C@H](CO)C1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"15.34";"0.29";"3.12";"9.82";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5094612";"";"None";"436.38";"0";"4.89";"478b";"Cn1cnnc1[C@H](F)[C@@](C)(F)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"13.75";"0.26";"1.11";"11.76";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5090539";"";"None";"384.89";"0";"4.48";"163";"CC(Sc1nncn1C)c1cccc(N2Cc3ccc(Cl)cc3C2=O)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"14.35";"0.29";"1.04";"10.82";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078812";"";"None";"390.37";"0";"4.39";"213b";"Cc1conc1C[C@H](C)c1cccc(NC(=O)c2ccnc(C(F)(F)F)n2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"14.15";"0.27";"1.13";"6.83";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5070348";"";"None";"436.87";"0";"4.34";"255a";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1.Cl";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5090112";"";"None";"381.51";"0";"4.44";"33";"CC(C)c1cccc(C(=O)Nc2cccc([C@H](C)Sc3nncn3C)c2)n1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"18.35";"0.35";"2.56";"9.63";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082208";"";"None";"418.39";"0";"4.81";"473";"CC(c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1)C(F)c1nncn1C";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"15.59";"0.30";"1.71";"12.78";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5085827";"";"None";"436.38";"0";"4.89";"478a";"Cn1cnnc1[C@@H](F)[C@](C)(F)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"14.94";"0.29";"1.63";"12.78";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086294";"";"None";"523.56";"1";"3.96";"429";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5C[C@H]6C[C@H]6C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076682";"";"None";"589.64";"1";"3.29";"430";"CC(c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O)N1CC(S(C)(=O)=O)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079179";"";"None";"552.52";"1";"4.72";"441";"CN1CCN(c2cc3c(c(C(F)(F)F)c2)CN(c2cccc([C@@](C)(F)C(F)(F)c4nncn4C)c2)C3=O)CC1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"12.67";"0.25";"2.28";"12.17";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5073677";"";"None";"578.56";"2";"5.25";"445";"CN1CC2CCC(C1)N2c1cc2c(c(C(F)(F)F)c1)CN(c1cccc([C@@](C)(F)C(F)(F)c3nncn3C)c1)C2=O";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078009";"";"None";"555.50";"2";"5.51";"449";"Cn1cnnc1C(F)(F)[C@@](C)(F)c1cccc(N2Cc3c(cc(CN4CC[C@H](F)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"11.74";"0.23";"1.01";"12.02";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082101";"";"None";"523.56";"1";"4.10";"486b";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CC[C@@H]6C[C@@H]65)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076720";"";"None";"459.55";"0";"2.45";"504";"Cn1cnnc1CC1(c2cccc(NC(=O)c3cc(CN4CCC4)nc(C4CC4)n3)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089720";"";"None";"551.57";"1";"4.28";"524";"C[C@@H]1CN(Cc2cc3c(c(C(F)(F)F)c2)CN(c2cccc(-c4c(-c5nncn5C)cnn4C)c2)C3=O)CCO1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088473";"";"None";"438.48";"0";"3.95";"526";"Cc1cc(C(=O)Nc2cccc(C3(Cc4nncn4C)CC(F)(F)C3)c2)nc(C2CC2)n1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5077288";"";"None";"539.56";"1";"3.23";"530";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CC5CNCCC5=O)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5074688";"";"None";"501.61";"1";"4.08";"538";"CC(c1cc2c(c(C3CC3)c1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O)N1CC(F)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079122";"";"None";"501.61";"1";"3.91";"554";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CC[C@H](F)C5)cc4C4CC4)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080543";"";"None";"565.64";"2";"5.44";"558b";"C[C@H](c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O)N1CCC2(CC1)CC2";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091136";"";"None";"538.57";"1";"3.45";"582";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(N5CCNC6(CC6)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082365";"";"None";"471.44";"0";"2.95";"598";"Cc1cc(C(=O)Nc2cccc(C3(Cc4nncn4C)COC3)c2)n2nc(C(F)(F)F)cc2n1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"14.85";"0.28";"4.05";"7.05";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082401";"";"None";"510.52";"1";"4.66";"616";"CC1=C(c2cc3c(c(C(F)(F)F)c2)CN(c2cccc(C4(Cc5nncn5C)COC4)c2)C3=O)CCO1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5090523";"";"None";"543.57";"1";"4.44";"623";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCC[C@@H](F)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076009";"";"None";"574.61";"1";"4.46";"638";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCc6ccncc6C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080801";"";"None";"529.54";"1";"4.22";"668a";"C[C@H](c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O)N1CC(F)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082688";"";"None";"543.57";"1";"4.96";"674b";"Cn1cnnc1[C@H](F)C1(c2cccc(N3Cc4c(cc(CN5CCCCC5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5084228";"";"None";"451.48";"0";"3.62";"677";"Cc1cc2c(c(C3CC3)n1)CN(c1cccc(C3(C(F)(F)c4nncn4C)COC3)c1)C2=O";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079854";"";"None";"455.48";"0";"4.79";"681";"C[C@H](Cc1nncn1C)c1cc(N2Cc3c(cccc3C(F)(F)F)C2=O)nc(C2(C)CC2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"14.32";"0.27";"1.73";"10.20";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5087571";"";"None";"418.50";"0";"2.94";"534b";"Cc1cc(C(=O)Nc2cccc([C@@]3(Cc4nncn4C)CCOC3)c2)nc(C2CC2)n1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078746";"";"None";"537.58";"2";"5.66";"535";"Cc1conc1CC1(c2cccc(N3Cc4c(cc(CN5CCC6(CC6)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5085244";"";"None";"498.63";"0";"3.92";"584";"CC(c1cc2c(c(C3CC3)n1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O)N1CCCC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086675";"";"None";"403.45";"0";"1.93";"596";"Cc1cc(C(=O)Nc2cccc(C3(Cc4nncn4C)COC3)c2)n2nccc2n1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"17.35";"0.32";"5.07";"7.05";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5077618";"";"None";"495.53";"0";"2.95";"610";"Cn1cnnc1CC1(c2cccc(NC(=O)c3cc(N4CC(C(F)F)C4)nc(C4CC4)n3)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079431";"";"None";"567.61";"1";"4.26";"703";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCOC6(CCC6)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5087377";"";"None";"498.55";"0";"4.14";"380";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc(N(C)[C@H]4CCNC4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5085631";"";"None";"529.54";"1";"4.05";"410";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CC[C@H](F)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5090289";"";"None";"436.46";"0";"4.95";"43";"COc1c(C(=O)Nc2cccc([C@H](C)Sc3nncn3C)c2)cccc1C(F)(F)F";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"12.65";"0.25";"0.57";"8.00";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076954";"";"None";"383.48";"0";"2.85";"46";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(CCO)ccn2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"15.65";"0.30";"3.15";"6.46";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082221";"";"None";"447.49";"1";"5.21";"67";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C3CC3)cc(C(F)(F)F)n2)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5077525";"";"None";"479.48";"0";"3.55";"84";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C3(O)COC3)cc(C(F)(F)F)n2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"13.60";"0.27";"2.97";"6.38";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5092035";"";"None";"424.41";"0";"3.61";"122";"C[C@H](Sc1nncn1C)c1ccnc(NC(=O)c2cccc(OC(F)(F)F)n2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"14.14";"0.28";"2.39";"6.33";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086731";"";"None";"450.57";"0";"3.94";"144";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CCCCC3)ccn2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"12.26";"0.24";"1.58";"5.94";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082980";"";"None";"466.57";"0";"2.91";"153";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3C[C@H](O)C[C@H]3C)ccn2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"11.84";"0.23";"2.61";"4.88";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091161";"";"None";"436.43";"0";"4.99";"168";"CC(Sc1nncn1C)c1cc(F)cc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"14.94";"0.30";"1.53";"12.78";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080287";"";"None";"492.53";"0";"4.04";"176";"CC(CO)Nc1cc(C(C)Sc2nncn2C)cc(N2Cc3c(cccc3C(F)(F)F)C2=O)n1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"13.24";"0.26";"2.48";"6.78";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076829";"";"None";"324.39";"0";"2.15";"197";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2ccn(C)n2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"18.49";"0.34";"3.85";"7.73";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078383";"";"None";"361.45";"0";"3.98";"212";"Cc1ccc(C(=O)Nc2cccc([C@H](C)Cc3nnc[nH]3)c2)nc1C1CC1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"18.04";"0.33";"2.54";"7.80";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5070012";"";"None";"502.50";"1";"3.03";"221";"C[C@@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CC[C@H](O)C3)cc(C(F)(F)F)n2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"12.98";"0.25";"3.49";"5.76";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080583";"";"None";"448.53";"0";"2.41";"222";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CC[C@](C)(O)C3)ccn2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"14.54";"0.27";"4.11";"5.76";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5084074";"";"None";"543.57";"1";"4.44";"435";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCC(C)(F)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5077962";"";"None";"541.47";"2";"5.12";"451";"Cn1cnnc1C(F)(F)[C@](C)(F)c1cccc(N2Cc3c(cc(CN4CC(F)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"12.93";"0.25";"1.88";"12.90";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093595";"";"None";"401.42";"0";"2.89";"188";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cccc(C(F)(F)CO)n2)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"17.44";"0.33";"4.11";"7.53";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5084821";"";"None";"418.39";"0";"4.42";"298b";"Cn1cnnc1C[C@](C)(F)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"16.73";"0.32";"2.58";"13.72";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076522";"";"None";"540.55";"1";"2.78";"391";"CN1CCN(c2cc3c(c(C(F)(F)F)c2)CN(c2cccc(C4(Cc5nncn5C)COC4)c2)C3=O)C(=O)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5094217";"";"None";"418.44";"0";"4.85";"166a";"C[C@H](Sc1nncn1C)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"16.73";"0.33";"2.15";"13.72";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089389";"";"None";"385.88";"0";"3.88";"167";"C[C@H](Sc1nncn1C)c1cccc(N2Cc3c(ccnc3Cl)C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"16.90";"0.34";"2.64";"10.20";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076787";"";"None";"421.50";"0";"3.10";"205";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(O[C@@H]3CC[C@@H](O)C3)ccn2)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5084267";"";"None";"434.50";"0";"2.33";"228";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)NC3CCOC3)ccn2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"12.71";"0.24";"3.19";"4.97";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5092156";"";"None";"452.38";"0";"3.99";"295";"Cn1cnnc1C(F)(F)C(C)(O)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"12.21";"0.24";"1.53";"7.75";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5085231";"";"None";"390.37";"0";"3.22";"302";"C[C@H](Cc1nncn1C)c1ccnc(NC(=O)c2cccc(C(F)(F)F)n2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"16.71";"0.32";"3.30";"7.62";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093172";"";"None";"470.50";"0";"4.70";"351";"C[C@H](Cc1nncn1C)c1cc(NC2CCC2)nc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"14.88";"0.28";"2.30";"9.22";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5072531";"";"None";"393.47";"0";"3.92";"373";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(ccnc3C(C)(C)F)C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"16.57";"0.31";"2.60";"10.20";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5074669";"";"None";"540.59";"1";"3.65";"389";"C[C@H]1CN(C)CCN1c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5074793";"";"None";"417.52";"0";"2.72";"80";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cccc(S(C)(=O)=O)n2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"14.37";"0.29";"3.28";"5.62";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5077495";"";"None";"404.50";"0";"4.06";"92";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2ccc(C#N)c(C3CC3)n2)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5085988";"";"None";"491.42";"1";"5.23";"94";"CC(Sc1nncn1C)c1ccc(OC(F)(F)F)c(NC(=O)c2cccc(C(F)(F)F)n2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"12.21";"0.25";"0.77";"7.32";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086770";"";"None";"422.51";"0";"3.16";"143";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CCC3)ccn2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"13.07";"0.25";"2.36";"5.94";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5085620";"";"None";"421.50";"0";"3.10";"207";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(O[C@@H]3CC[C@H](O)C3)ccn2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"15.47";"0.29";"3.42";"6.38";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079567";"";"None";"373.46";"0";"3.59";"257";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(ccnc3C3CC3)C2=O)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"18.74";"0.34";"3.41";"10.95";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089690";"";"None";"383.48";"0";"3.71";"90";"CCOc1cccc(C(=O)Nc2cccc([C@H](C)Sc3nncn3C)c2)n1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"15.65";"0.30";"2.29";"7.32";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080358";"";"None";"461.44";"0";"3.05";"190";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C3(O)COC3)cc(C(F)(F)F)n2)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"15.17";"0.29";"3.95";"6.85";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5075293";"";"None";"365.44";"0";"2.34";"202";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cccc(CCO)n2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"17.85";"0.33";"4.18";"7.02";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076757";"";"None";"420.52";"0";"3.13";"204";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(N[C@@H]3CC[C@H](O)C3)ccn2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"14.27";"0.26";"2.87";"5.72";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078242";"";"None";"462.55";"0";"2.79";"231";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CCC(O)C3(C)C)ccn2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"12.97";"0.24";"3.21";"5.30";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5085664";"";"None";"418.39";"0";"4.48";"281";"CC(Cc1nncn1C)c1cc(F)cc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"16.73";"0.32";"2.52";"13.72";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5087087";"";"None";"502.50";"1";"3.03";"220";"CC(Cc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CC[C@H](O)C3)cc(C(F)(F)F)n2)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086915";"";"None";"561.57";"0";"2.37";"230";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CC[C@@](C)(N)C3)ccn2)c1.O=C(O)C(F)(F)F";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"12.34";"0.23";"3.15";"4.64";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076510";"";"None";"421.51";"0";"1.76";"244";"CNCCNC(=O)c1ccnc(C(=O)Nc2cccc([C@H](C)Cc3nncn3C)c2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"14.23";"0.26";"4.24";"5.27";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5071626";"";"None";"471.56";"0";"3.02";"278";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc(C(=O)N4CC(O)C4)cc3C3CC3)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079361";"";"None";"411.46";"0";"4.54";"286";"Cc1ccc(C(=O)Nc2cccc(C(C)C(F)(F)c3nncn3C)c2)nc1C1CC1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"17.01";"0.32";"2.46";"9.63";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5085811";"";"None";"447.46";"0";"4.05";"320";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C(C)(C)O)cc(C(F)(F)F)n2)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"15.64";"0.30";"2.95";"7.53";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5090060";"";"None";"375.44";"0";"2.76";"329";"Cc1cc(C(=O)Nc2cccc([C@H](C)Cc3nncn3C)c2)nc2ccnn12";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"18.64";"0.34";"4.24";"7.78";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089798";"";"None";"379.49";"0";"4.11";"334";"Cc1cc(C(=O)Nc2cccc([C@H](C)Cc3nncs3)c2)nc(C2CC2)n1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"18.45";"0.35";"2.89";"8.68";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5077784";"";"None";"456.43";"0";"3.47";"335";"Cn1cnnc1CC1(c2cccc(NC(=O)c3nc4c(C(F)(F)F)cccc4[nH]3)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5090846";"";"None";"430.43";"0";"4.02";"344";"Cc1cc(C(=O)Nc2cccc([C@@](C)(F)C(F)(F)c3nncn3C)c2)nc(C2CC2)n1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"16.26";"0.31";"2.98";"8.18";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5092603";"";"None";"486.50";"0";"3.94";"349";"C[C@H](Cc1nncn1C)c1cc(NC2(C)COC2)nc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"13.40";"0.25";"2.58";"7.66";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089405";"";"None";"505.49";"1";"4.79";"402";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc(CN4CC(F)(F)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082925";"";"None";"543.57";"1";"4.61";"413";"C[C@H](c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O)N1CC[C@H](F)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086746";"";"None";"538.50";"1";"4.38";"442";"Cn1cnnc1C(F)(F)[C@](C)(F)c1cccc(N2Cc3c(cc(N4CCNCC4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082495";"";"None";"573.49";"2";"5.81";"448";"Cn1cnnc1C(F)(F)[C@](C)(F)c1cccc(N2Cc3c(cc(CN4CCC(F)(F)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5084790";"";"None";"566.50";"2";"5.19";"465";"C[C@H](CC1=NN=CC1C(F)(F)F)c1cccc(N2Cc3c(cc(C(=O)N4CC[C@H](O)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093480";"";"None";"513.54";"2";"5.37";"466";"CC(c1cc2c(c(C(F)(F)F)c1)CN(c1cccc([C@H]3C[C@H]3c3nncn3C)c1)C2=O)N1CC[C@H](F)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088340";"";"None";"454.37";"0";"4.88";"471b";"Cn1cnnc1C[C@@H](c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1)C(F)(F)F";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"12.15";"0.24";"0.64";"10.82";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091382";"";"None";"418.39";"0";"4.81";"474a";"C[C@@H](c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1)[C@@H](F)c1nncn1C";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5075626";"";"None";"393.52";"0";"4.50";"53";"Cc1cnc(C(=O)Nc2cccc([C@H](C)Sc3nncn3C)c2)cc1C1CC1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"14.03";"0.27";"1.02";"7.60";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5090534";"";"None";"421.45";"0";"4.64";"65";"Cc1cc(C(=O)Nc2cccc([C@H](C)Sc3nncn3C)c2)nc(C(F)(F)F)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5070499";"";"None";"437.45";"0";"4.34";"71";"COc1cc(C(=O)Nc2cccc([C@H](C)Sc3nncn3C)c2)nc(C(F)(F)F)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"16.00";"0.32";"2.66";"8.54";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079579";"";"None";"371.44";"0";"3.79";"87";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cccc(CF)n2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"16.15";"0.32";"2.21";"8.25";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5077934";"";"None";"448.47";"0";"4.61";"104";"C[C@H](Sc1nncn1C)c1ccnc(NC(=O)c2cc(C3CC3)cc(C(F)(F)F)n2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"14.54";"0.29";"1.91";"7.62";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5094363";"";"None";"458.47";"0";"4.88";"111";"C[C@H](Sc1nncn1C)c1ccnc(NC(=O)c2cc(C(F)(F)F)c3ccccc3n2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"12.05";"0.24";"0.64";"6.45";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093305";"";"None";"442.85";"0";"4.38";"114";"C[C@H](Sc1nncn1C)c1ccnc(NC(=O)c2cc(C(F)(F)F)c(Cl)cn2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"12.47";"0.26";"1.14";"6.45";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086637";"";"None";"577.61";"1";"4.19";"652";"Cn1cc2c(n1)CCCN2Cc1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5075411";"";"None";"589.62";"2";"5.03";"656";"COc1ccc2c(c1)CN(Cc1cc3c(c(C(F)(F)F)c1)CN(c1cccc(C4(Cc5nncn5C)COC4)c1)C3=O)C2";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093733";"";"None";"448.53";"0";"2.95";"690";"CCOc1cc(NC(=O)c2cc(C)nc(C3CC3)n2)cc(C2(Cc3nncn3C)COC2)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086918";"";"None";"423.42";"0";"3.05";"492";"Cn1cnnc1CC1(c2cccc(NC(=O)c3csc(C(F)(F)F)n3)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5077457";"";"None";"455.47";"0";"3.45";"502";"Cn1cnnc1CC1(c2cccc(NC(=O)c3cc(OC(F)F)cc(C4CC4)n3)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5075573";"";"None";"447.54";"0";"2.31";"503";"CN(C)Cc1cc(C(=O)Nc2cccc(C3(Cc4nncn4C)COC3)c2)nc(C2CC2)n1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080581";"";"None";"390.49";"0";"3.56";"511";"Cc1cc(C(=O)Nc2cccc(C(C)(C)Cc3nncn3C)c2)nc(C2CC2)n1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5092238";"";"None";"551.61";"1";"4.88";"517a";"Cn1cnnc1C[C@@]1(c2cccc(N3Cc4c(cc(CN5CCC6(CC6)C5)cc4C(F)(F)F)C3=O)c2)CCOC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078126";"";"None";"438.41";"0";"4.06";"523";"Cn1cnnc1-c1cnn(C)c1-c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"15.97";"0.30";"2.94";"10.17";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083104";"";"None";"575.58";"2";"5.13";"528";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCCC(F)(F)CC5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091685";"";"None";"555.60";"1";"3.36";"532";"CN1CC[C@@H](O)[C@H](Cc2cc3c(c(C(F)(F)F)c2)CN(c2cccc(C4(Cc5nncn5C)COC4)c2)C3=O)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078409";"";"None";"578.56";"2";"5.25";"564";"CN1C2CCC1CN(c1cc3c(c(C(F)(F)F)c1)CN(c1cccc([C@@](C)(F)C(F)(F)c4nncn4C)c1)C3=O)C2";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5071483";"";"None";"441.54";"0";"3.64";"568";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(C5CC5)nc4C4CC4)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5094565";"";"None";"579.54";"2";"5.16";"570";"C[C@@H](c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3(C(F)(F)c4nncn4C)COC3)c1)C2=O)N1CC[C@H](F)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5081933";"";"None";"569.60";"2";"5.52";"575";"C[C@@H](c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3([C@@H](F)c4nncn4C)COC3)c1)C2=O)N1CCC2(CC2)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089701";"";"None";"484.60";"0";"3.35";"579";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCCC5)nc4C4CC4)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5081014";"";"None";"421.50";"0";"3.10";"206";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(O[C@H]3CC[C@@H](O)C3)ccn2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"15.47";"0.29";"3.42";"6.38";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086828";"";"None";"386.37";"1";"5.20";"261";"C[C@H](Cc1ncco1)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"14.29";"0.27";"0.32";"11.92";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5085108";"";"None";"418.39";"0";"4.81";"293";"C[C@@H](c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1)[C@H](F)c1nncn1C";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"16.73";"0.32";"2.19";"13.72";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5071853";"";"None";"361.41";"0";"2.46";"318";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cn3ccnc3cn2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"18.04";"0.33";"4.06";"7.25";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5081763";"";"None";"404.47";"0";"2.55";"336";"Cc1cc(C(=O)Nc2cccc(C3(Cc4nncn4C)COC3)c2)nc(C2CC2)n1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5084643";"";"None";"445.45";"0";"4.13";"358";"CCOc1cc([C@H](C)Cc2nncn2C)cc(N2Cc3c(cccc3C(F)(F)F)C2=O)n1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088950";"";"None";"517.53";"1";"3.86";"395";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc(CN4C[C@@H](O)[C@H](F)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5081960";"";"None";"513.56";"1";"4.47";"416";"CC(c1cc2c(c(C(F)(F)F)c1)CN(c1cccc([C@H](C)Cc3nncn3C)c1)C2=O)N1CC[C@H](O)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5081708";"";"None";"525.53";"1";"3.20";"427";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CC=C[C@@H]5O)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089376";"";"None";"454.50";"1";"5.61";"476";"CC(Cc1nncn1C)c1cc(C2CCC2)cc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"14.35";"0.27";"0.91";"12.78";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5094574";"";"None";"436.38";"0";"4.89";"480";"Cn1cnnc1[C@@H](F)[C@@](C)(F)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"16.04";"0.31";"2.11";"13.72";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5081938";"";"None";"476.45";"1";"5.77";"481a";"Cn1cnnc1[C@H](F)[C@](C)(F)c1cccc(N2Cc3c(cc(C4CC4)cc3C(F)(F)F)C2=O)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"14.69";"0.28";"1.23";"13.72";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088609";"";"None";"369.45";"0";"2.92";"50";"CC1=CC(C(=O)Nc2cccc([C@H](C)Sc3nncn3C)c2)=NC(=O)C1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"14.95";"0.29";"2.60";"6.19";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088127";"";"None";"379.49";"0";"4.19";"72";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cccc(C3CC3)n2)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091302";"";"None";"396.50";"0";"3.93";"121";"C[C@H](Sc1nncn1C)c1ccnc(NC(=O)c2nc3ccccc3s2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"13.93";"0.28";"1.59";"6.45";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076700";"";"None";"419.51";"0";"4.48";"62";"COc1nc(C(=O)Nc2cccc([C@H](C)Sc3nncn3C)c2)cc2ccccc12";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"16.69";"0.32";"2.52";"8.54";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5077499";"";"None";"466.57";"0";"2.91";"150";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CCC[C@H](O)C3)ccn2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"11.84";"0.23";"2.61";"4.88";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093016";"";"None";"408.41";"0";"3.73";"77";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cncc(C(F)(F)F)n2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"15.97";"0.32";"2.79";"7.62";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5085382";"";"None";"414.44";"0";"3.79";"118";"C[C@H](Sc1nncn1C)c1ccnc(NC(=O)c2csc(C(F)(F)F)n2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"14.48";"0.30";"2.21";"7.01";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088367";"";"None";"447.54";"0";"3.01";"253";"C[C@H](Cc1nccn1C)c1cccc(NC(=O)c2cc(C(=O)N3C[C@@H](O)C[C@H]3C)ccn2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"12.34";"0.23";"2.51";"5.50";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089235";"";"None";"354.44";"0";"3.02";"82";"Cc1cncc(C(=O)Nc2cccc([C@H](C)Sc3nncn3C)c2)n1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"16.93";"0.33";"2.98";"7.01";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093332";"";"None";"375.46";"0";"4.46";"98";"C[C@H](Sc1nnc[nH]1)c1cccc(NC(=O)c2cc3ccccc3cn2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"17.37";"0.33";"2.06";"7.80";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5090445";"";"None";"400.48";"0";"3.92";"110";"C[C@H](Sc1nncn1C)c1ccnc(NC(=O)c2cccc(C(C)(C)F)n2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"16.28";"0.32";"2.60";"7.62";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5075387";"";"None";"443.51";"0";"2.79";"238";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CC[C@@H](C#N)C3)ccn2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"13.53";"0.25";"3.21";"5.14";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5092942";"";"None";"448.53";"0";"2.26";"245";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CCC(CO)C3)ccn2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"13.38";"0.25";"3.74";"5.30";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5077820";"";"None";"441.87";"0";"4.99";"51";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2ccc(Cl)c(C(F)(F)F)n2)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"15.84";"0.33";"2.01";"9.63";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5077505";"";"None";"462.55";"0";"2.89";"251";"CCn1cnnc1C[C@@H](C)c1cccc(NC(=O)c2cc(C(=O)N3C[C@@H](O)C[C@H]3C)ccn2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"14.10";"0.26";"3.63";"5.76";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5073063";"";"None";"415.42";"0";"4.43";"271a";"C[C@@H](Cc1n[nH]cc1CO)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"";""
"CHEMBL5083287";"";"None";"404.40";"0";"3.40";"285";"Cn1cnnc1CC(C)(C)c1cccc(NC(=O)c2ccnc(C(F)(F)F)n2)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"17.31";"0.33";"3.60";"8.18";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5090257";"";"None";"416.40";"0";"3.44";"297";"Cn1cnnc1CC(C)(O)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"13.26";"0.25";"2.08";"7.75";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5070490";"";"None";"488.60";"0";"2.00";"348";"CN1CCN(c2nc(C(=O)Nc3cccc(C4(Cc5nncn5C)COC4)c3)cc(C3CC3)n2)CC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093779";"";"None";"436.43";"0";"4.99";"168b";"C[C@@H](Sc1nncn1C)c1cc(F)cc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"13.75";"0.27";"1.01";"11.76";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5077176";"";"None";"439.54";"0";"3.09";"198";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(S(C)(=O)=O)cc(C3CC3)n2)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"15.93";"0.31";"3.91";"6.55";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078482";"";"None";"415.42";"0";"4.43";"271";"CC(Cc1n[nH]cc1CO)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"13.29";"0.25";"1.09";"7.98";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083072";"";"None";"367.48";"0";"3.93";"35";"Cc1ccc(C(=O)Nc2cccc([C@H](C)Sc3nncn3C)c2)nc1C";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"17.75";"0.34";"2.59";"8.97";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089995";"";"None";"431.95";"0";"4.20";"55";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C(C)(C)O)c(Cl)cn2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"15.10";"0.31";"2.32";"7.02";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082033";"";"None";"475.42";"1";"5.35";"64";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)n2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"13.72";"0.28";"1.17";"8.97";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082295";"";"None";"404.88";"0";"3.37";"125";"COc1nc(C(=O)Nc2cc([C@H](C)Sc3nncn3C)ccn2)ccc1Cl";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"14.82";"0.30";"2.63";"6.33";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088894";"";"None";"415.52";"1";"5.03";"135";"C=CCC(Sc1nncn1C)c1cccc(NC(=O)c2cc3ccccc3cn2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"14.44";"0.27";"0.97";"8.25";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5075297";"";"None";"452.54";"0";"2.52";"139";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CC[C@@H](O)C3)ccn2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"12.20";"0.24";"3.00";"4.88";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5085414";"";"None";"466.57";"0";"2.91";"151";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3C[C@H](O)C[C@@H]3C)ccn2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"13.98";"0.27";"3.61";"5.76";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076039";"";"None";"418.44";"0";"4.85";"166b";"C[C@@H](Sc1nncn1C)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"14.34";"0.28";"1.15";"11.76";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078253";"";"None";"452.49";"0";"1.96";"235";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3C[C@H](O)[C@@H](F)C3)ccn2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"13.26";"0.25";"4.04";"5.30";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086003";"";"None";"444.41";"0";"4.04";"273";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc(C(=O)O)cc3C(F)(F)F)C2=O)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"13.50";"0.26";"1.96";"6.79";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080910";"";"None";"416.40";"0";"3.92";"290";"COC(Cc1nncn1C)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"14.41";"0.27";"2.08";"9.96";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082934";"";"None";"529.54";"1";"4.22";"668b";"C[C@@H](c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O)N1CC(F)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083675";"";"None";"489.58";"0";"1.81";"505";"Cn1cnnc1CC1(c2cccc(NC(=O)c3cc(CN4CC[C@H](O)C4)nc(C4CC4)n3)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5084463";"";"None";"471.53";"0";"1.89";"506";"Cn1cnnc1CC1(c2cccc(NC(=O)c3cc(Cn4ccnn4)nc(C4CC4)n3)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078019";"";"None";"472.47";"0";"3.56";"540";"CC(O)c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089428";"";"None";"537.59";"1";"4.31";"560";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(C5CN6CCC5CC6)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078342";"";"None";"512.53";"1";"4.40";"615";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(C5CCCOC5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5087335";"";"None";"415.52";"1";"5.03";"134";"C=CCC(Sc1nncn1C)c1cccc(NC(=O)c2ccc3ccccc3n2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"14.44";"0.27";"0.97";"8.25";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5084230";"";"None";"452.54";"0";"2.52";"140";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CC[C@H](O)C3)ccn2)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"15.47";"0.30";"4.48";"6.18";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080100";"";"None";"451.56";"0";"2.49";"146";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CC[C@@H](N)C3)ccn2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"12.23";"0.24";"3.03";"4.64";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5077089";"";"None";"597.60";"0";"3.24";"210";"C[C@@H](Cc1nncn1C)c1cccc(NC(=O)c2cc3cc(N4CCN(C)C(=O)C4)ccc3cn2)c1.O=C(O)C(F)(F)F";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"11.42";"0.21";"2.28";"5.74";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082809";"";"None";"398.39";"0";"4.27";"282";"Cn1cnnc1[C@@H]1C[C@@H]1c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"16.37";"0.31";"2.25";"12.78";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078107";"";"None";"454.37";"0";"4.97";"296b";"Cn1cnnc1C(F)(F)[C@@](C)(F)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"12.15";"0.24";"0.55";"10.82";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5071043";"";"None";"414.43";"0";"4.51";"300";"Cn1cnnc1CC(C)(C)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5074090";"";"None";"497.52";"0";"3.96";"607";"CC1CN(c2cc3c(c(C(F)(F)F)c2)CN(c2cccc(C4(Cc5nncn5C)COC4)c2)C3=O)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5075393";"";"None";"511.55";"1";"4.35";"608";"CC1CN(c2cc3c(c(C(F)(F)F)c2)CN(c2cccc(C4(Cc5nncn5C)COC4)c2)C3=O)C1C";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079896";"";"None";"555.58";"1";"4.96";"618";"Cn1cnnc1[C@@H](F)C1(c2cccc(N3Cc4c(cc(CN5CCC6(CC6)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086583";"";"None";"569.63";"1";"4.51";"629";"CCOC1CCCN(Cc2cc3c(c(C(F)(F)F)c2)CN(c2cccc(C4(Cc5nncn5C)COC4)c2)C3=O)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5071203";"";"None";"557.59";"1";"4.68";"639b";"C[C@H]1CCN(Cc2cc3c(c(C(F)(F)F)c2)CN(c2cccc(C4(Cc5nncn5C)COC4)c2)C3=O)C[C@H]1F";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086502";"";"None";"459.47";"0";"4.52";"688";"CCCOc1cc([C@H](C)Cc2nncn2C)cc(N2Cc3c(cccc3C(F)(F)F)C2=O)n1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"14.19";"0.27";"2.00";"8.92";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080611";"";"None";"545.54";"1";"4.23";"700";"Cn1cnnc1OC1(c2cccc(N3Cc4c(cc(CN5CCC(F)CC5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"12.83";"0.25";"2.77";"9.63";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086356";"";"None";"407.47";"0";"4.61";"96a";"C[C@H](Sc1nncn1C)c1ccc(F)c(NC(=O)c2ccc3ccccc3n2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"14.72";"0.28";"1.39";"8.25";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088307";"";"None";"416.40";"0";"4.69";"269";"CC(Cc1nocc1CO)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"14.41";"0.27";"1.31";"9.01";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080792";"";"None";"476.56";"0";"3.59";"306b";"CNC(=O)COc1ccc2cnc(C(=O)Nc3cccc([C@@H](C)Sc4nncn4C)c3)cc2c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"11.59";"0.22";"1.93";"4.97";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089755";"";"None";"552.60";"1";"3.79";"387";"CN1CC2CCC1CN2c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5085363";"";"None";"515.56";"2";"5.45";"404";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc([C@H](C)N4CC[C@H](F)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5094182";"";"None";"547.53";"1";"4.00";"414";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5C[C@@H](F)[C@@H](F)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5081059";"";"None";"401.39";"0";"3.74";"304b";"C[C@H](Cc1nncn1C)c1ccnc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"16.25";"0.31";"2.78";"10.20";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5071825";"";"None";"374.45";"0";"3.31";"333";"Cc1cc(C(=O)Nc2cccc([C@H]3C[C@H]3c3nncn3C)c2)nc(C2CC2)n1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"18.69";"0.34";"3.69";"8.18";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086758";"";"None";"460.46";"0";"3.14";"357";"C[C@H](Cc1nncn1C)c1cc(NCCO)nc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"15.20";"0.29";"3.86";"7.28";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5073213";"";"None";"494.52";"1";"5.35";"378";"Cc1n[nH]c(C)c1-c1cc2c(c(C(F)(F)F)c1)CN(c1cccc([C@H](C)Cc3nncn3C)c1)C2=O";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079463";"";"None";"561.56";"1";"4.91";"419";"C[C@H](c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O)N1CCC(F)(F)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5087525";"";"None";"536.56";"1";"3.85";"422";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CC[C@H](C#N)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5094783";"";"None";"562.52";"2";"5.32";"454";"Cn1cnnc1C(F)(F)[C@](C)(F)c1cccc(N2Cc3c(cc(CN4CC[C@H](C#N)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080112";"";"None";"561.56";"1";"4.39";"634";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CC[C@@H](F)[C@@H](F)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5087155";"";"None";"577.61";"1";"4.19";"651";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCCc6c5cnn6C)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5094462";"";"None";"587.65";"2";"5.49";"662b";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CC[C@@H](c6ccccc6)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5074877";"";"None";"541.57";"1";"3.73";"663b";"C[C@@H]1CN(Cc2cc3c(c(C(F)(F)F)c2)CN(c2cccc(C4(Cc5nncn5C)COC4)c2)C3=O)CCO1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093826";"";"None";"483.49";"0";"4.54";"685";"C[C@H](Cc1nncn1C)c1cc(C2=CCOCC2)nc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"13.49";"0.25";"1.98";"8.92";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5072301";"";"None";"589.62";"2";"5.03";"702";"COc1cccc2c1CN(Cc1cc3c(c(C(F)(F)F)c1)CN(c1cccc(C4(Cc5nncn5C)COC4)c1)C3=O)C2";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5070631";"";"None";"440.45";"0";"3.41";"704";"Cc1cc(C(=O)Nc2cccc(C3(Cc4nncn4C(F)F)COC3)c2)nc(C2CC2)n1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076851";"";"None";"598.63";"1";"4.93";"706";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCc6cc(C#N)ccc6C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083388";"";"None";"609.57";"1";"4.66";"715";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCOC(CC(F)(F)F)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5085149";"";"None";"490.58";"0";"3.39";"496";"Cn1cnnc1CC1(c2cccc(NC(=O)c3cc(CN4CC[C@H](F)C4)cc(C4CC4)n3)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083657";"";"None";"484.60";"0";"3.30";"498";"Cn1cnnc1CC1(c2cccc(NC(=O)c3cc(CN4C[C@H]5C[C@H]5C4)cc(C4CC4)n3)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076994";"";"None";"520.58";"1";"3.55";"499";"Cn1cnnc1CC1(c2cccc(NC(=O)c3cc(CN4C[C@@H]5[C@H](C4)C5(F)F)cc(C4CC4)n3)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078994";"";"None";"499.62";"0";"4.40";"508";"Cc1conc1CC1(c2cccc(NC(=O)c3cc(CN4CCC5(CC5)C4)nc(C4CC4)n3)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5085779";"";"None";"404.47";"0";"3.72";"509";"Cc1cc(C(=O)Nc2cccc(C3(Cc4nocc4C)COC3)c2)nc(C2CC2)n1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079305";"";"None";"403.49";"0";"3.46";"510";"Cc1cc(C(=O)Nc2cccc(C3(Cc4[nH]ncc4C)COC3)c2)nc(C2CC2)n1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5092467";"";"None";"517.53";"1";"4.26";"512";"Cn1cnnc1C(F)(F)[C@](C)(F)c1cccc(NC(=O)c2cc(CN3CC[C@H](F)C3)nc(C3CC3)n2)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078733";"";"None";"498.63";"0";"3.84";"519";"Cn1cnnc1CC1(c2cccc(NC(=O)c3cc(CN4CCC5(CC5)C4)cc(C4CC4)n3)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5094413";"";"None";"543.57";"1";"4.44";"536";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CC(F)C5(C)C)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083110";"";"None";"537.59";"1";"4.52";"541b";"C[C@H](c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O)N1CC2CC2C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5081651";"";"None";"508.45";"1";"3.59";"547";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(C(F)(F)CO)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5084135";"";"None";"570.51";"1";"4.72";"551";"CN(c1cc2c(c(C(F)(F)F)c1)CN(c1cccc([C@@](C)(F)C(F)(F)c3nncn3C)c1)C2=O)[C@@H]1CNC[C@H]1F";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5081552";"";"None";"571.62";"2";"5.39";"553b";"C[C@H](c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O)N1CCC(C)(F)CC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093181";"";"None";"565.64";"2";"5.44";"558a";"C[C@@H](c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O)N1CCC2(CC1)CC2";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5070560";"";"None";"536.59";"1";"2.69";"572";"CN1CC2CC(C1)N2c1cc(C(=O)Nc2cccc(C3(C(F)(F)c4nncn4C)COC3)c2)nc(C2CC2)n1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5071646";"";"None";"524.67";"1";"4.31";"585";"CC(c1cc2c(c(C3CC3)n1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O)N1CCC2(CC2)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5090066";"";"None";"552.60";"1";"3.79";"590";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(N5CCN6CCC[C@@H]6C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086026";"";"None";"487.61";"0";"3.40";"593";"CC(c1cc(C(=O)Nc2cccc(C3(Cc4nncn4C)COC3)c2)nc(C2CC2)n1)N1CCCC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091522";"";"None";"494.42";"0";"4.11";"595";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(OC(F)F)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5084091";"";"None";"471.44";"0";"2.95";"599";"Cc1cnn2c(C(=O)Nc3cccc(C4(Cc5nncn5C)COC4)c3)cc(C(F)(F)F)nc12";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"13.83";"0.26";"3.57";"6.57";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5081482";"";"None";"551.49";"1";"4.50";"600";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(N5CC(C(F)(F)F)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5075010";"";"None";"540.59";"1";"3.25";"625";"CN1CCN(Cc2cc3c(c(C(F)(F)F)c2)CN(c2cccc(C4(Cc5nncn5C)COC4)c2)C3=O)CC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5075189";"";"None";"561.56";"1";"4.39";"626b";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CC[C@@H](F)[C@H](F)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5073039";"";"None";"557.59";"1";"4.68";"631";"C[C@@H]1CCN(Cc2cc3c(c(C(F)(F)F)c2)CN(c2cccc(C4(Cc5nncn5C)COC4)c2)C3=O)C[C@H]1F";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086670";"";"None";"564.61";"1";"4.63";"642";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCC(C)(C#N)CC5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5075615";"";"None";"577.55";"1";"3.71";"647";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCC(F)(F)C(O)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5084814";"";"None";"574.61";"1";"4.46";"648";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCc6cnccc6C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5092986";"";"None";"587.65";"2";"5.49";"662a";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CC[C@H](c6ccccc6)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5077788";"";"None";"541.57";"1";"3.73";"663a";"C[C@H]1CN(Cc2cc3c(c(C(F)(F)F)c2)CN(c2cccc(C4(Cc5nncn5C)COC4)c2)C3=O)CCO1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079840";"";"None";"555.60";"1";"4.11";"664";"C[C@@H]1CN(Cc2cc3c(c(C(F)(F)F)c2)CN(c2cccc(C4(Cc5nncn5C)COC4)c2)C3=O)C[C@H](C)O1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088561";"";"None";"561.56";"1";"4.91";"670b";"Cn1cnnc1[C@H](F)C1(c2cccc(N3Cc4c(cc(CN5CCC(F)CC5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5077931";"";"None";"587.59";"2";"5.44";"672a";"Cn1cnnc1[C@@H](F)C1(c2cccc(N3Cc4c(cc(CN5[C@H]6CC[C@H]5CC(F)C6)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5081095";"";"None";"587.59";"2";"5.44";"672b";"Cn1cnnc1[C@H](F)C1(c2cccc(N3Cc4c(cc(CN5[C@H]6CC[C@H]5CC(F)C6)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076071";"";"None";"484.51";"0";"4.86";"682";"C[C@H](Cc1nncn1C)c1cc(-c2cncs2)nc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"13.46";"0.26";"1.66";"8.49";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079687";"";"None";"486.50";"0";"3.67";"689";"C[C@H](Cc1nncn1C)c1cc(NC2CCC2O)nc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"13.40";"0.25";"2.85";"6.78";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5073479";"";"None";"574.61";"1";"4.46";"709";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCc6ncccc6C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5087928";"";"None";"580.61";"1";"3.31";"711";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCN6C(=O)CCC6C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5074602";"";"None";"389.38";"0";"3.83";"184";"C[C@@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C(F)(F)F)ccn2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"15.41";"0.29";"2.17";"8.25";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5074425";"";"None";"429.45";"0";"4.70";"191";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C3CC3)cc(C(F)(F)F)n2)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079118";"";"None";"402.50";"0";"3.96";"193";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C3CC3)nc(C3CC3)n2)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086539";"";"None";"388.39";"0";"4.66";"216";"Cc1ccn(CC(C)c2cccc(NC(=O)c3cccc(C(F)(F)F)n3)c2)n1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"14.22";"0.27";"0.86";"9.23";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5092981";"";"None";"391.35";"0";"3.04";"219";"CC(Cn1[nH]cnc1=O)c1cccc(NC(=O)c2cccc(C(F)(F)F)n2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"14.11";"0.27";"2.48";"5.96";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078035";"";"None";"436.52";"0";"2.31";"226";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)NCC(C)(C)O)ccn2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"12.65";"0.24";"3.21";"4.53";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082805";"";"None";"447.54";"0";"2.37";"229";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CC[C@](C)(N)C3)ccn2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"13.41";"0.25";"3.63";"5.04";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093985";"";"None";"452.49";"0";"1.96";"240";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3C[C@@H](O)[C@H](F)C3)ccn2)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"15.47";"0.29";"5.04";"6.18";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5077555";"";"None";"433.52";"0";"1.90";"248";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N[C@H]3CCNC3)ccn2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"12.74";"0.24";"3.62";"4.85";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5069653";"";"None";"451.50";"0";"2.76";"254";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CC[C@H](O)C3)ccc2F)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"13.29";"0.25";"3.24";"5.98";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088567";"";"None";"411.30";"0";"4.08";"256";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(Br)cccc3C2=O)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"17.02";"0.37";"2.92";"13.72";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089818";"";"None";"440.47";"1";"5.22";"260";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc(C4CC4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5081286";"";"None";"426.44";"1";"5.14";"265";"C[C@H](Cc1nncn1C1CC1)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"15.29";"0.29";"1.38";"12.78";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080606";"";"None";"454.37";"0";"4.88";"289";"Cn1cnnc1CC(c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1)C(F)(F)F";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"14.35";"0.28";"1.64";"12.78";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5094882";"";"None";"412.42";"0";"4.27";"299";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cccc4C(F)(F)F)C3=O)c2)CC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086904";"";"None";"372.43";"0";"3.36";"303";"C[C@H](Cc1nncn1C)c1ccnc(NC(=O)c2ccc3ccccc3n2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"17.51";"0.32";"3.16";"7.62";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5077353";"";"None";"476.56";"0";"3.59";"310";"CNC(=O)COc1cccc2nc(C(=O)Nc3cccc([C@H](C)Sc4nncn4C)c3)ccc12";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"13.68";"0.26";"2.93";"5.87";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093232";"";"None";"389.38";"0";"4.06";"312b";"Cc1cnnn1C[C@H](C)c1cccc(NC(=O)c2cccc(C(F)(F)F)n2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"15.41";"0.29";"1.94";"8.25";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082494";"";"None";"430.51";"0";"3.12";"347";"Cn1cnnc1CC1(c2cccc(NC(=O)c3cc(C4CC4)nc(C4CC4)n3)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076591";"";"None";"430.43";"0";"3.78";"363";"CNc1cc([C@H](C)Cc2nncn2C)cc(N2Cc3c(cccc3C(F)(F)F)C2=O)n1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078503";"";"None";"474.49";"0";"3.53";"364";"C[C@H](O)CNc1cc([C@H](C)Cc2nncn2C)cc(N2Cc3c(cccc3C(F)(F)F)C2=O)n1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"13.74";"0.26";"2.99";"6.78";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5085450";"";"None";"458.48";"0";"4.57";"374";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc(C(C)(C)O)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078549";"";"None";"480.49";"1";"5.04";"381";"Cc1[nH]ncc1-c1cc2c(c(C(F)(F)F)c1)CN(c1cccc([C@H](C)Cc3nncn3C)c1)C2=O";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088226";"";"None";"483.54";"0";"4.81";"383";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc([C@H]4CCCNC4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5090229";"";"None";"552.60";"1";"3.79";"386";"CN1CC2CCC(C1)N2c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5074919";"";"None";"501.53";"1";"4.88";"400";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc(CN4CC[C@@H](F)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076608";"";"None";"487.50";"0";"4.49";"401";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc(CN4CC(F)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083470";"";"None";"547.53";"1";"4.35";"411";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCC(F)(F)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5073973";"";"None";"535.52";"1";"4.15";"417";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc(CN4CC(O)C(F)(F)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082325";"";"None";"529.54";"1";"4.05";"424";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CC(C)(F)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5071247";"";"None";"474.49";"0";"4.42";"469";"CCOc1cc(NC(=O)c2cc(C)nc(C3CC3)n2)cc([C@@](C)(F)C(F)(F)c2nncn2C)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"14.75";"0.28";"2.58";"7.38";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5087072";"";"None";"523.56";"1";"4.10";"486a";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CC[C@H]6C[C@H]65)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076291";"";"None";"526.44";"1";"4.10";"580";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(C(O)C(F)(F)F)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079229";"";"None";"512.66";"1";"4.31";"587";"CC(c1cc2c(c(C3CC3)n1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O)N1CCCCC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082303";"";"None";"552.60";"1";"3.79";"591";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(N5CCN6CCC[C@H]6C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093857";"";"None";"482.51";"0";"4.77";"611";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(C5CCC5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091009";"";"None";"587.62";"2";"5.01";"691b";"CCOc1cc(N2Cc3c(cc([C@H](C)N4CC[C@H](F)C4)cc3C(F)(F)F)C2=O)cc(C2(Cc3nncn3C)COC2)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076188";"";"None";"395.49";"0";"2.91";"493";"Cn1cnnc1CC1(c2cccc(NC(=O)c3nc(C4CC4)cs3)c2)COC1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"16.49";"0.32";"3.61";"7.96";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089123";"";"None";"498.63";"1";"5.00";"500";"Cc1conc1CC1(c2cccc(NC(=O)c3cc(CN4CCC5(CC5)C4)cc(C4CC4)n3)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091215";"";"None";"418.53";"0";"4.32";"45";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cccc(-c3ccnn3C)c2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"13.20";"0.25";"1.20";"7.11";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5081942";"";"None";"437.45";"0";"4.34";"73";"COc1cc(C(F)(F)F)cc(C(=O)Nc2cccc([C@H](C)Sc3nncn3C)c2)n1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"13.71";"0.27";"1.66";"7.32";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5087792";"";"None";"395.51";"0";"4.53";"88";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cccc3scnc23)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"15.17";"0.30";"1.47";"8.25";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080113";"";"None";"403.51";"0";"4.78";"129";"Cc1cn(C)c(SC(C)c2ccnc(NC(=O)c3ccc4ccccc4n3)c2)n1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"";""
"CHEMBL5075090";"";"None";"459.58";"0";"4.62";"131";"CC(Sc1nncn1C)c1cc(NC(=O)c2ccc3ccccc3n2)c2c(c1)C(C)(O)CC2";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"12.02";"0.23";"0.90";"5.94";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079329";"";"None";"451.56";"0";"2.49";"147";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CC[C@H](N)C3)ccn2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"12.23";"0.24";"3.03";"4.64";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5073557";"";"None";"466.57";"0";"2.91";"154";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3C[C@@H](O)C[C@@H]3C)ccn2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"11.84";"0.23";"2.61";"4.88";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5077906";"";"None";"583.61";"1";"3.50";"712";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCOC6(CCOC6)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086701";"";"None";"555.50";"2";"5.51";"450";"Cn1cnnc1C(F)(F)[C@](C)(F)c1cccc(N2Cc3c(cc(CN4CC[C@@H](F)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089232";"";"None";"615.60";"1";"4.59";"458";"Cn1cnnc1C(F)(F)[C@](C)(F)c1cccc(N2Cc3c(cc(CN4CC[C@@H](S(C)(=O)=O)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088061";"";"None";"498.55";"1";"5.00";"463";"CC1C=NN=C1C[C@@H](C)c1cccc(N2Cc3c(cc(CN4CC[C@@H](O)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079603";"";"None";"454.50";"1";"5.39";"477";"Cn1cnnc1CC(C)(C)c1cccc(N2Cc3c(cc(C4CC4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5094573";"";"None";"555.60";"1";"3.36";"533";"CN1CC[C@H](O)[C@H](Cc2cc3c(c(C(F)(F)F)c2)CN(c2cccc(C4(Cc5nncn5C)COC4)c2)C3=O)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091331";"";"None";"491.57";"0";"2.79";"574";"Cn1cnnc1CC1(c2cccc(NC(=O)c3cc(CN4CC[C@H](F)C4)nc(C4CC4)n3)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076644";"";"None";"419.43";"0";"4.24";"172b";"C[C@@H](Sc1nncn1C)c1ccnc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"13.17";"0.26";"1.28";"8.64";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089970";"";"None";"391.48";"0";"3.18";"203";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2ccc(CO)c(C3CC3)n2)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5090006";"";"None";"460.54";"0";"2.81";"237";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CCC4(CCO4)C3)ccn2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"11.99";"0.22";"2.71";"5.40";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080164";"";"None";"448.53";"0";"2.26";"241";"CC(O)C1CN(C(=O)c2ccnc(C(=O)Nc3cccc([C@H](C)Cc4nncn4C)c3)c2)C1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"12.31";"0.23";"3.26";"4.88";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091777";"";"None";"433.52";"0";"1.90";"247";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N[C@@H]3CCNC3)ccn2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"12.74";"0.24";"3.62";"4.85";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083890";"";"None";"447.54";"0";"2.24";"249";"CN[C@@H]1CCN(C(=O)c2ccnc(C(=O)Nc3cccc([C@H](C)Cc4nncn4C)c3)c2)C1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"13.41";"0.25";"3.76";"5.71";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079366";"";"None";"454.37";"0";"4.97";"296";"Cn1cnnc1C(F)(F)C(C)(F)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"14.35";"0.28";"1.55";"12.78";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088718";"";"None";"471.48";"0";"4.15";"350";"C[C@H](Cc1nncn1C)c1cc(NC2COC2)cc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"13.83";"0.26";"2.37";"9.02";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5087863";"";"None";"515.51";"1";"3.66";"415";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CC(F)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091285";"";"None";"561.56";"1";"4.91";"420";"C[C@@H](c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O)N1CCC(F)(F)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088666";"";"None";"421.45";"0";"4.64";"61";"Cc1ccc(C(=O)Nc2cccc([C@H](C)Sc3nncn3C)c2)nc1C(F)(F)F";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"16.61";"0.33";"2.36";"9.63";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078209";"";"None";"466.57";"0";"2.91";"152";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3C[C@@H](O)C[C@H]3C)ccn2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"11.84";"0.23";"2.61";"4.88";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5075109";"";"None";"390.37";"0";"3.45";"217";"Cc1nnnn1CC(C)c1cccc(NC(=O)c2cccc(C(F)(F)F)n2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"";""
"CHEMBL5077484";"";"None";"387.49";"0";"3.98";"258";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(ccnc3C3CCC3)C2=O)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"18.06";"0.33";"3.02";"10.95";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5070842";"";"None";"428.41";"0";"3.51";"301";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cccc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5092933";"";"None";"407.42";"0";"4.33";"57a";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cccc(C(F)(F)F)n2)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"17.18";"0.34";"2.67";"9.63";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082110";"";"None";"397.48";"0";"4.33";"91";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2ccc(F)c(C3CC3)n2)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5072332";"";"None";"408.46";"0";"4.00";"107";"C[C@H](Sc1nncn1C)c1ccnc(NC(=O)c2ccc3cccc(F)c3n2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"14.69";"0.28";"2.00";"7.01";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078470";"";"None";"394.50";"0";"3.90";"70";"Cc1ncc(C(=O)Nc2cccc([C@H](C)Sc3nncn3C)c2)nc1C1CC1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"17.74";"0.34";"3.10";"8.18";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5071566";"";"None";"446.46";"0";"4.82";"120";"C[C@H](Sc1nncn1C)c1ccnc(NC(=O)c2cc3c(C(F)(F)F)cccc3[nH]2)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"15.68";"0.31";"2.18";"7.91";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091233";"";"None";"510.64";"1";"3.92";"586";"CC(c1cc2c(c(C3CC3)n1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O)N1CC2(CC2)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5073017";"";"None";"542.07";"1";"2.92";"311";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc3cc(OCC(=O)NCCN)ccc3cn2)c1.Cl";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"13.84";"0.27";"4.08";"5.11";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083065";"";"None";"499.51";"0";"4.81";"409";"Cn1cnnc1[C@@H]1C[C@@H]1c1cccc(N2Cc3c(cc(CN4CC[C@H](F)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089004";"";"None";"569.53";"2";"6.08";"459";"C[C@H](c1cc2c(c(C(F)(F)F)c1)CN(c1cccc([C@@](C)(F)C(F)(F)c3nncn3C)c1)C2=O)N1CC[C@H](F)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076727";"";"None";"450.57";"0";"3.94";"142";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CCC[C@H]3C)ccn2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"";""
"CHEMBL5093279";"";"None";"438.51";"0";"2.13";"148";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CC(O)C3)ccn2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"14.87";"0.29";"4.39";"5.76";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082837";"";"None";"466.57";"0";"2.91";"149";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CCC[C@@H](O)C3)ccn2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"11.84";"0.23";"2.61";"4.88";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078783";"";"None";"440.53";"0";"2.43";"156";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)NC[C@@H](C)O)ccn2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"12.54";"0.24";"3.09";"4.53";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079581";"";"None";"470.48";"0";"2.26";"243";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CC(O)C(F)(F)C3)ccn2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"13.86";"0.26";"4.26";"5.76";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5085720";"";"None";"447.54";"0";"2.24";"250";"CN[C@H]1CCN(C(=O)c2ccnc(C(=O)Nc3cccc([C@H](C)Cc4nncn4C)c3)c2)C1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"13.41";"0.25";"3.76";"5.71";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5077472";"";"None";"433.51";"0";"2.62";"252a";"C[C@H](Cc1nccn1C)c1cccc(NC(=O)c2cc(C(=O)N3CC[C@H](O)C3)ccn2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"13.84";"0.26";"3.38";"5.98";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083992";"";"None";"513.52";"1";"3.55";"274";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc(C(=O)N4CC[C@H](O)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083114";"";"None";"499.49";"0";"3.16";"276";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc(C(=O)N4CC(O)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5077320";"";"None";"466.47";"0";"4.73";"279";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc(-c4ccn[nH]4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5073173";"";"None";"400.40";"0";"4.34";"255b";"C[C@@H](Cc1nncn1C)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"14.98";"0.28";"1.66";"11.76";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080412";"";"None";"476.45";"1";"5.77";"483";"Cn1cnnc1[C@@H](F)[C@](C)(F)c1cccc(N2Cc3c(cc(C4CC4)cc3C(F)(F)F)C2=O)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"14.69";"0.28";"1.23";"13.72";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5075987";"";"None";"537.59";"1";"4.52";"541a";"C[C@@H](c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O)N1CC2CC2C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5081087";"";"None";"570.51";"1";"4.72";"548";"CN(c1cc2c(c(C(F)(F)F)c1)CN(c1cccc([C@@](C)(F)C(F)(F)c3nncn3C)c1)C2=O)[C@@H]1CNC[C@@H]1F";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"12.27";"0.24";"2.28";"10.56";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093564";"";"None";"564.53";"1";"4.86";"562";"CN1C[C@@H]2C[C@H]1CN2c1cc2c(c(C(F)(F)F)c1)CN(c1cccc([C@@](C)(F)C(F)(F)c3nncn3C)c1)C2=O";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5092505";"";"None";"538.57";"1";"3.40";"569";"CN1C[C@@H]2C[C@H]1CN2c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5094490";"";"None";"506.56";"1";"3.46";"609";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(N5CC(C(F)F)C5)nc4C4CC4)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093211";"";"None";"573.59";"1";"4.06";"621";"CO[C@@H]1CCN(Cc2cc3c(c(C(F)(F)F)c2)CN(c2cccc(C4(Cc5nncn5C)COC4)c2)C3=O)C[C@@H]1F";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086484";"";"None";"561.56";"1";"4.39";"626a";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CC[C@H](F)[C@@H](F)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5069736";"";"None";"415.50";"0";"3.07";"692";"Cc1cc2c(c(C3CC3)n1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078664";"";"None";"414.47";"0";"3.11";"522";"Cc1cc(C(=O)Nc2cccc(-c3c(-c4nncn4C)cnn3C)c2)nc(C2CC2)n1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"16.89";"0.31";"3.89";"6.77";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086220";"";"None";"403.51";"0";"4.78";"48";"Cc1cccc2nc(C(=O)Nc3cccc([C@H](C)Sc4nncn4C)c3)ccc12";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"16.16";"0.31";"1.74";"8.97";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088448";"";"None";"380.48";"0";"3.59";"76";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2ccnc(C3CC3)n2)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5077338";"";"None";"419.51";"0";"4.48";"97";"COc1ccc(C(C)Sc2nncn2C)cc1NC(=O)c1ccc2ccccc2n1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"14.30";"0.27";"1.52";"7.32";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089137";"";"None";"442.85";"0";"4.38";"106";"C[C@H](Sc1nncn1C)c1ccnc(NC(=O)c2ccc(Cl)c(C(F)(F)F)n2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"13.55";"0.28";"1.62";"7.01";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5092727";"";"None";"380.43";"0";"3.46";"115";"C[C@H](Sc1nncn1C)c1ccnc(NC(=O)c2noc3ccccc23)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"14.52";"0.28";"2.06";"5.59";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086311";"";"None";"380.48";"0";"3.59";"117";"C[C@H](Sc1nncn1C)c1ccnc(NC(=O)c2cccc(C3CC3)n2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"15.77";"0.30";"2.41";"7.01";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086325";"";"None";"374.86";"0";"3.36";"124";"C[C@H](Sc1nncn1C)c1ccnc(NC(=O)c2cccc(Cl)n2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"16.00";"0.33";"2.64";"7.01";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5071735";"";"None";"466.57";"0";"3.18";"141";"CO[C@@H]1CCN(C(=O)c2ccnc(C(=O)Nc3cccc([C@H](C)Sc4nncn4C)c3)c2)C1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"11.84";"0.23";"2.34";"5.40";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079662";"";"None";"364.45";"0";"3.02";"327";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2[nH]nc3c2CCCC3)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"17.89";"0.33";"3.50";"7.37";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086323";"";"None";"504.54";"1";"4.44";"179";"CC(Sc1nncn1C)c1cc(NC2CCOC2)nc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"10.95";"0.22";"1.08";"6.48";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5094036";"";"None";"390.37";"0";"4.39";"213a";"Cc1conc1C[C@@H](C)c1cccc(NC(=O)c2ccnc(C(F)(F)F)n2)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"17.93";"0.34";"2.61";"8.65";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078100";"";"None";"448.53";"0";"2.40";"224";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3C[C@@H](O)C[C@H]3C)ccn2)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"15.61";"0.29";"4.60";"6.18";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5087908";"";"None";"433.52";"0";"1.85";"242";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CCNCC3)ccn2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"12.74";"0.24";"3.67";"5.26";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088633";"";"None";"452.49";"0";"1.96";"246";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3C[C@@H](F)[C@@H](O)C3)ccn2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"13.26";"0.25";"4.04";"5.30";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5077957";"";"None";"499.54";"0";"3.91";"397";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc(CN4CC(C)(O)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5084293";"";"None";"423.40";"0";"4.14";"408";"Cn1cnnc1[C@@H]1C[C@@H]1c1cccc(N2Cc3c(cc(C#N)cc3C(F)(F)F)C2=O)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"16.53";"0.31";"2.86";"9.36";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5087389";"";"None";"553.59";"1";"3.87";"433";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCCC56COC6)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076102";"";"None";"567.49";"1";"4.18";"438";"Cn1cnnc1C(F)(F)[C@](C)(F)c1cccc(N2Cc3c(cc(C(=O)N4CC[C@H](O)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089193";"";"None";"587.47";"2";"5.31";"439";"Cn1cnnc1C(F)(F)[C@](C)(F)c1cccc(N2Cc3c(cc(C(=O)N4CC(C(F)F)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"11.10";"0.22";"1.21";"9.14";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5074551";"";"None";"566.55";"2";"5.11";"444";"C[C@H]1CN(C)CCN1c1cc2c(c(C(F)(F)F)c1)CN(c1cccc([C@@](C)(F)C(F)(F)c3nncn3C)c1)C2=O";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078613";"";"None";"389.38";"0";"4.06";"312a";"Cc1cnnn1C[C@@H](C)c1cccc(NC(=O)c2cccc(C(F)(F)F)n2)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"17.98";"0.34";"2.94";"9.63";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5070118";"";"None";"378.36";"0";"3.16";"314";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C(F)(F)F)n[nH]2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"17.24";"0.33";"3.36";"7.37";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080818";"";"None";"522.53";"1";"3.46";"423";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CC(C#N)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5077504";"";"None";"543.57";"1";"4.44";"432";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCC[C@H](F)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5087951";"";"None";"566.55";"2";"5.11";"443";"C[C@@H]1CN(C)CCN1c1cc2c(c(C(F)(F)F)c1)CN(c1cccc([C@@](C)(F)C(F)(F)c3nncn3C)c1)C2=O";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078873";"";"None";"502.62";"1";"4.24";"501";"Cc1conc1CC1(c2cccc(NC(=O)c3cc(CN4CCO[C@H](C)C4)cc(C4CC4)n3)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079546";"";"None";"460.54";"0";"2.67";"233";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CCC4(COC4)C3)ccn2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"11.99";"0.22";"2.85";"5.40";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080011";"";"None";"569.60";"2";"5.52";"515";"C[C@@H](c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3([C@H](F)c4nncn4C)COC3)c1)C2=O)N1CCC2(CC2)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076526";"";"None";"393.52";"0";"4.50";"54";"Cc1ccc(C(=O)Nc2cccc([C@H](C)Sc3nncn3C)c2)nc1C1CC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080328";"";"None";"396.48";"0";"3.27";"59";"CC(=O)Nc1ccnc(C(=O)Nc2cccc([C@H](C)Sc3nncn3C)c2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"15.13";"0.29";"2.73";"5.89";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082889";"";"None";"394.50";"0";"3.59";"108";"C[C@H](Sc1nncn1C)c1ccnc(NC(=O)c2ccc3c(n2)CCCC3)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"15.21";"0.29";"2.41";"7.01";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5071540";"";"None";"533.50";"1";"4.21";"594";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(N5CC(C(F)F)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078704";"";"None";"537.59";"1";"4.35";"646";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCC6CC6C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086278";"";"None";"557.57";"1";"2.70";"710";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCO[C@H](CO)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5087278";"";"None";"476.45";"1";"5.77";"481b";"Cn1cnnc1[C@@H](F)[C@@](C)(F)c1cccc(N2Cc3c(cc(C4CC4)cc3C(F)(F)F)C2=O)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"12.59";"0.24";"0.23";"11.76";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089103";"";"None";"529.54";"1";"4.57";"673a";"Cn1cnnc1[C@@H](F)C1(c2cccc(N3Cc4c(cc(CN5CCCC5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083391";"";"None";"407.42";"0";"4.33";"57b";"C[C@@H](Sc1nncn1C)c1cccc(NC(=O)c2cccc(C(F)(F)F)n2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"14.73";"0.29";"1.67";"8.25";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5072244";"";"None";"368.47";"0";"3.36";"60";"CNc1ccnc(C(=O)Nc2cccc([C@H](C)Sc3nncn3C)c2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"16.28";"0.32";"2.64";"7.08";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088216";"";"None";"457.48";"1";"5.49";"63";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc3ccccc3c(C(F)(F)F)n2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"12.07";"0.24";"0.03";"7.60";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5092537";"";"None";"422.43";"0";"4.82";"79";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cccc(OC(F)(F)F)c2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"13.07";"0.26";"0.70";"8.00";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5084834";"";"None";"457.48";"1";"5.49";"83";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C(F)(F)F)c3ccccc3n2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"13.11";"0.26";"0.51";"8.25";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5087834";"";"None";"462.56";"0";"2.05";"86";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(NS(=O)(=O)CCO)ccn2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"11.94";"0.24";"3.47";"3.97";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093907";"";"None";"442.85";"0";"4.38";"105";"C[C@H](Sc1nncn1C)c1ccnc(NC(=O)c2cc(Cl)cc(C(F)(F)F)n2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"14.73";"0.31";"2.14";"7.62";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5077582";"";"None";"487.31";"0";"4.49";"119";"C[C@H](Sc1nncn1C)c1ccnc(NC(=O)c2cc(Br)cc(C(F)(F)F)n2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"13.38";"0.31";"2.03";"7.62";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093883";"";"None";"384.89";"0";"4.48";"164";"C[C@H](Sc1nncn1C)c1cccc(N2Cc3cc(Cl)ccc3C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"16.94";"0.34";"2.04";"12.78";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5085332";"";"None";"362.44";"0";"3.08";"199";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2ccnc(C3CC3)n2)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5094681";"";"None";"367.48";"0";"3.93";"56";"Cc1cc(C)nc(C(=O)Nc2cccc([C@H](C)Sc3nncn3C)c2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"17.75";"0.34";"2.59";"8.97";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5090069";"";"None";"389.48";"0";"4.47";"8";"CC(Sc1nncn1C)c1cccc(NC(=O)c2cc3ccccc3cn2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"15.40";"0.29";"1.53";"8.25";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5092339";"";"None";"408.53";"0";"4.06";"165";"CC(Sc1nncn1C)c1cccc(N2Cc3ccc(C(C)(C)O)cc3C2=O)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"13.52";"0.26";"1.46";"7.75";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086253";"";"None";"453.57";"0";"3.57";"198b";"CCn1cnnc1C[C@H](C)c1cccc(NC(=O)c2cc(S(C)(=O)=O)cc(C3CC3)n2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"12.18";"0.24";"1.95";"5.17";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083486";"";"None";"389.38";"0";"4.06";"218";"Cc1cnnn1CC(C)c1cccc(NC(=O)c2cccc(C(F)(F)F)n2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"16.75";"0.32";"2.46";"8.97";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5090881";"";"None";"462.55";"0";"2.65";"239";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CC(O)C(C)(C)C3)ccn2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"12.97";"0.24";"3.35";"5.30";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076064";"";"None";"400.49";"0";"4.17";"319";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2nc3c(C4CC4)cccc3[nH]2)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"17.48";"0.32";"2.83";"7.91";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5087574";"";"None";"361.41";"0";"2.46";"324";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cnn3cccnc23)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"18.04";"0.33";"4.06";"7.25";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076117";"";"None";"487.48";"0";"3.90";"355";"CC1OCC1Oc1cc([C@H](C)Cc2nncn2C)cc(N2Cc3c(cccc3C(F)(F)F)C2=O)n1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"13.38";"0.25";"2.62";"7.92";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079897";"";"None";"486.50";"0";"3.94";"362";"C[C@H](Cc1nncn1C)c1cc(N[C@@H]2CCOC2)nc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"14.39";"0.27";"3.06";"8.22";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5094156";"";"None";"403.43";"1";"5.06";"368";"C[C@H](Cc1nncs1)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"16.16";"0.32";"1.46";"14.15";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083367";"";"None";"552.60";"1";"3.79";"388";"CN1C2CCC1CN(c1cc3c(c(C(F)(F)F)c1)CN(c1cccc(C4(Cc5nncn5C)COC4)c1)C3=O)C2";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5077072";"";"None";"543.57";"1";"4.61";"543b";"C[C@H](c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O)N1CC(C)(F)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078708";"";"None";"557.59";"1";"5.00";"545";"CC[C@@H](c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O)N1CC[C@H](F)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089887";"";"None";"557.59";"1";"5.00";"546";"CC[C@H](c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O)N1CC[C@H](F)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088425";"";"None";"537.59";"1";"4.63";"555";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5C6CCC5CC6)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080907";"";"None";"418.47";"0";"3.50";"577";"Cn1cnnc1CC1(c2cccc(N3Cc4c(ccc(F)c4C4CC4)C3=O)c2)COC1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"16.73";"0.31";"3.50";"11.62";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082021";"";"None";"381.51";"0";"3.99";"26";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cccc(N(C)C)c2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"";""
"CHEMBL5087334";"";"None";"441.87";"0";"4.99";"40";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C(F)(F)F)c(Cl)cn2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"13.58";"0.28";"1.01";"8.25";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093786";"";"None";"441.87";"0";"4.99";"68";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(Cl)cc(C(F)(F)F)n2)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"15.84";"0.33";"2.01";"9.63";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5073689";"";"None";"447.49";"1";"5.21";"69";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C(F)(F)F)cc(C3CC3)n2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"14.57";"0.29";"1.31";"8.97";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089210";"";"None";"571.60";"1";"3.35";"667";"COC[C@@H]1CN(Cc2cc3c(c(C(F)(F)F)c2)CN(c2cccc(C4(Cc5nncn5C)COC4)c2)C3=O)CCO1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5090764";"";"None";"422.46";"0";"3.02";"669b";"Cc1cc(C(=O)Nc2cccc(C3([C@@H](F)c4nncn4C)COC3)c2)nc(C2CC2)n1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5074467";"";"None";"569.60";"2";"5.49";"671b";"Cn1cnnc1[C@H](F)C1(c2cccc(N3Cc4c(cc(CN5C6CCCC5CC6)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078039";"";"None";"422.44";"0";"4.04";"103";"Cc1cc(C(=O)Nc2cc([C@H](C)Sc3nncn3C)ccn2)nc(C(F)(F)F)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"15.44";"0.31";"2.48";"7.62";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083768";"";"None";"415.42";"0";"4.43";"271b";"C[C@H](Cc1n[nH]cc1CO)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"14.44";"0.27";"1.57";"8.67";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088496";"";"None";"399.42";"1";"5.24";"272";"Cc1[nH]cnc1CC(C)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"16.33";"0.31";"1.28";"13.31";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079370";"";"None";"399.42";"1";"5.24";"272a";"Cc1[nH]cnc1C[C@@H](C)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"17.53";"0.33";"1.76";"14.29";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5094009";"";"None";"418.39";"0";"4.42";"298a";"Cn1cnnc1C[C@@](C)(F)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"14.34";"0.27";"1.58";"11.76";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5094104";"";"None";"401.39";"0";"3.74";"304a";"C[C@@H](Cc1nncn1C)c1ccnc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"13.76";"0.26";"1.78";"8.64";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082720";"";"None";"463.52";"0";"3.93";"305";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc3cc(OCC(=O)O)ccc3cn2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"14.07";"0.27";"2.59";"5.47";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5074775";"";"None";"394.44";"0";"1.63";"343";"Cn1cnnc1CC1(c2cccc(NC(=O)c3[nH]nc4c3OCCC4)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088882";"";"None";"424.46";"0";"3.87";"346";"Cc1cc(C(=O)Nc2cccc(C3(C(F)(F)c4nncn4C)CC3)c2)nc(C2CC2)n1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5075956";"";"None";"541.53";"1";"3.02";"428";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CC(C(=O)O)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5075034";"";"None";"516.52";"1";"3.21";"475";"Cn1cnnc1CC(C)(C)c1cccc(NC(=O)c2cc(C(=O)N3CC[C@H](O)C3)cc(C(F)(F)F)n2)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5075844";"";"None";"436.38";"0";"4.89";"479";"Cn1cnnc1[C@H](F)[C@](C)(F)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086794";"";"None";"436.38";"0";"4.89";"294";"CC(c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1)C(F)(F)c1nncn1C";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"14.94";"0.29";"1.63";"12.78";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5087323";"";"None";"403.49";"0";"3.16";"339";"Cc1cc(C(=O)Nc2cccc(C3(Cc4nncn4C)COC3)c2)nc(C2CC2)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5075487";"";"None";"472.47";"0";"3.55";"352";"C[C@H](Cc1nncn1C)c1cc(NC2COC2)nc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080911";"";"None";"567.49";"2";"5.43";"484";"C[C@H](Cc1nocc1C(F)(F)F)c1cccc(N2Cc3c(cc(C(=O)N4CC[C@H](O)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"12.34";"0.24";"1.57";"8.06";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5085233";"";"None";"484.48";"0";"4.05";"513";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(OC5CC5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5085977";"";"None";"499.49";"0";"2.86";"514";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(OC5CNC5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091058";"";"None";"389.48";"0";"4.47";"8a";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc3ccccc3cn2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"16.74";"0.32";"2.05";"8.97";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089320";"";"None";"409.52";"0";"3.69";"89";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2ccc(CO)c(C3CC3)n2)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5077399";"";"None";"499.54";"0";"4.08";"405";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc([C@@H](C)N4CC(O)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088901";"";"None";"517.53";"1";"3.86";"418";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc(CN4C[C@@H](F)[C@@H](O)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089037";"";"None";"549.45";"2";"6.17";"440";"Cn1cnnc1C(F)(F)[C@](C)(F)c1cccc(N2Cc3c(cc(-c4cncc(F)c4)cc3C(F)(F)F)C2=O)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"12.74";"0.25";"0.83";"10.95";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5085643";"";"None";"399.42";"0";"4.95";"267";"CC(Cc1nccn1C)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"13.83";"0.26";"0.57";"14.48";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082036";"";"None";"412.42";"0";"4.51";"375";"C[C@@H]1[C@@H](c2nncn2C)[C@H]1c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083522";"";"None";"510.52";"1";"4.31";"614";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(C5=CCCOC5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078010";"";"None";"393.52";"0";"4.19";"23";"CC(Sc1nncn1C)c1cccc(NC(=O)c2ccc3c(n2)CCCC3)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"15.25";"0.29";"1.81";"8.25";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5092314";"";"None";"403.51";"0";"4.78";"30";"Cc1cc(C(=O)Nc2cccc([C@H](C)Sc3nncn3C)c2)nc2ccccc12";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"16.16";"0.31";"1.74";"8.97";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5071171";"";"None";"389.48";"0";"4.47";"8b";"C[C@@H](Sc1nncn1C)c1cccc(NC(=O)c2cc3ccccc3cn2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"14.18";"0.27";"1.05";"7.60";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076551";"";"None";"466.57";"0";"2.91";"145";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CCC(O)CC3)ccn2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"12.86";"0.25";"3.09";"5.30";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086287";"";"None";"408.49";"0";"2.58";"173";"CNC(=O)c1ccc2c(c1)C(=O)N(c1cc(C(C)Sc3nncn3C)ccn1)C2";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"13.52";"0.26";"2.94";"5.94";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091573";"";"None";"492.53";"0";"4.04";"177";"CC(Sc1nncn1C)c1cc(NC[C@H](C)O)nc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"11.21";"0.22";"1.48";"5.74";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091431";"";"None";"418.38";"0";"2.39";"337";"Cn1cnnc1CC1(c2cccc(NC(=O)c3ccnc(C(F)(F)F)n3)c2)COC1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"16.73";"0.32";"4.61";"7.38";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083332";"";"None";"458.44";"0";"3.26";"341";"Cn1cnnc1CC1(c2cccc(NC(=O)c3cc(C4CC4)nc(C(F)(F)F)n3)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5084590";"";"None";"458.49";"0";"4.56";"353";"CC(C)Nc1cc([C@H](C)Cc2nncn2C)cc(N2Cc3c(cccc3C(F)(F)F)C2=O)n1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091852";"";"None";"461.44";"0";"3.11";"359";"C[C@H](Cc1nncn1C)c1cc(OCCO)nc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"14.13";"0.27";"3.41";"6.98";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5073280";"";"None";"413.53";"0";"4.47";"370";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc(C4CC4)nc3C3CC3)C2=O)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"16.93";"0.31";"2.53";"10.95";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5072236";"";"None";"480.49";"1";"5.04";"377";"Cc1c[nH]nc1-c1cc2c(c(C(F)(F)F)c1)CN(c1cccc([C@H](C)Cc3nncn3C)c1)C2=O";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5084791";"";"None";"483.54";"0";"4.81";"382";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc([C@@H]4CCCNC4)cc3C(F)(F)F)C2=O)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"14.48";"0.27";"2.19";"11.10";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5084259";"";"None";"430.43";"0";"3.83";"392";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc(CO)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080374";"";"None";"519.52";"2";"5.18";"396";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc(CN4CCC(F)(F)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078532";"";"None";"499.54";"0";"4.08";"406";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc([C@H](C)N4CC(O)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5081451";"";"None";"375.48";"0";"3.84";"259";"CC(C)c1nccc2c1CN(c1cccc([C@H](C)Cc3nncn3C)c1)C2=O";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"17.37";"0.32";"2.68";"10.20";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080124";"";"None";"543.57";"1";"4.61";"412";"C[C@@H](c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O)N1CC[C@H](F)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5087296";"";"None";"525.53";"1";"3.63";"426";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCCC5=O)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5074732";"";"None";"444.46";"0";"4.39";"436";"CC(O)c1cc2c(c(C(F)(F)F)c1)CN(c1cccc([C@H](C)Cc3nncn3C)c1)C2=O";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082897";"";"None";"412.42";"0";"4.66";"283b";"Cn1cnnc1[C@@H]1CC[C@@H]1c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"15.81";"0.30";"1.86";"12.78";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091981";"";"None";"403.41";"0";"4.00";"284";"Cn1cnnc1CC(C)(C)c1cccc(NC(=O)c2cccc(C(F)(F)F)n2)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5069583";"";"None";"427.46";"0";"3.73";"287";"CC(c1cccc(NC(=O)c2ccc(CO)c(C3CC3)n2)c1)C(F)(F)c1nncn1C";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"16.38";"0.31";"3.27";"7.53";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5077821";"";"None";"555.50";"2";"5.51";"447";"Cn1cnnc1C(F)(F)[C@](C)(F)c1cccc(N2Cc3c(cc(CN4CC[C@H](F)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083818";"";"None";"492.03";"0";"3.37";"472";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc3cc(N4CCNCC4)ccc3cn2)c1.Cl";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5081904";"";"None";"360.42";"0";"3.06";"317";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc3cccn3cn2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"18.09";"0.33";"3.46";"8.46";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5073892";"";"None";"569.63";"1";"4.36";"716";"CC(C)C1CN(Cc2cc3c(c(C(F)(F)F)c2)CN(c2cccc(C4(Cc5nncn5C)COC4)c2)C3=O)CCO1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076844";"";"None";"429.48";"0";"2.50";"604";"Cn1cnnc1CC1(c2cccc(NC(=O)c3cc(C4CC4)nc4ccnn34)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5092620";"";"None";"557.59";"1";"4.83";"627";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCCCC(F)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079281";"";"None";"557.59";"1";"4.68";"639a";"C[C@@H]1CCN(Cc2cc3c(c(C(F)(F)F)c2)CN(c2cccc(C4(Cc5nncn5C)COC4)c2)C3=O)C[C@@H]1F";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093339";"";"None";"561.56";"1";"4.91";"670a";"Cn1cnnc1[C@@H](F)C1(c2cccc(N3Cc4c(cc(CN5CCC(F)CC5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083954";"";"None";"569.60";"2";"5.49";"671a";"Cn1cnnc1[C@@H](F)C1(c2cccc(N3Cc4c(cc(CN5C6CCCC5CC6)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5074854";"";"None";"529.54";"1";"4.57";"673b";"Cn1cnnc1[C@H](F)C1(c2cccc(N3Cc4c(cc(CN5CCCC5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076762";"";"None";"481.48";"0";"4.43";"683";"Cc1c[nH]nc1-c1cc([C@H](C)Cc2nncn2C)cc(N2Cc3c(cccc3C(F)(F)F)C2=O)n1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"14.54";"0.27";"2.57";"7.56";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078251";"";"None";"485.51";"0";"4.63";"686";"C[C@H](Cc1nncn1C)c1cc(C2CCOCC2)nc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"13.43";"0.25";"1.89";"8.92";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080862";"";"None";"417.47";"0";"2.24";"597";"Cc1cc(C(=O)Nc2cccc(C3(Cc4nncn4C)COC3)c2)n2nc(C)cc2n1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"16.77";"0.31";"4.76";"7.05";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5085466";"";"None";"557.59";"1";"4.83";"620";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCC(C)(F)CC5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091213";"";"None";"591.58";"1";"3.95";"644b";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CC[C@H](CO)C(F)(F)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5090326";"";"None";"574.61";"1";"4.46";"645";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCc6cccnc6C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093221";"";"None";"559.59";"2";"5.02";"654";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5Cc6ccccc6C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086295";"";"None";"594.04";"2";"5.67";"659";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5Cc6ccc(Cl)cc6C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082567";"";"None";"555.60";"1";"4.12";"665";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCOC(C)(C)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088229";"";"None";"553.59";"1";"3.87";"666";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCOC6(CC6)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5084412";"";"None";"422.46";"0";"3.02";"669a";"Cc1cc(C(=O)Nc2cccc(C3([C@H](F)c4nncn4C)COC3)c2)nc(C2CC2)n1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083954";"";"None";"569.60";"2";"5.49";"675a";"Cn1cnnc1[C@@H](F)C1(c2cccc(N3Cc4c(cc(CN5C6CCCC5CC6)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091762";"";"None";"565.52";"1";"4.77";"679";"CC(c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3(C(F)(F)c4nncn4C)COC3)c1)C2=O)N1CC(F)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083206";"";"None";"441.46";"0";"4.61";"680";"C[C@H](Cc1nncn1C)c1cc(C2CC2)nc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086622";"";"None";"444.54";"0";"3.43";"698";"Cc1cc(C(=O)Nc2cc(C3CC3)cc(C3(Cc4nncn4C)COC3)c2)nc(C2CC2)n1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083513";"";"None";"595.54";"1";"4.27";"707";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCO[C@H](C(F)(F)F)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5075287";"";"None";"559.56";"1";"3.68";"714";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCOC(CF)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5085153";"";"None";"400.40";"0";"4.34";"264";"C[C@H](Cc1ncnn1C)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"13.79";"0.26";"1.18";"10.82";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083648";"";"None";"377.49";"0";"4.11";"321";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cccc(C(C)(C)C)n2)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091686";"";"None";"361.41";"0";"2.46";"328";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2ccnc3ccnn23)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079610";"";"None";"420.47";"0";"2.25";"342";"COc1cc(C(=O)Nc2cccc(C3(Cc4nncn4C)COC3)c2)nc(C2CC2)n1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078393";"";"None";"401.39";"0";"3.74";"371";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(ccnc3C(F)(F)F)C2=O)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"17.44";"0.33";"3.26";"10.95";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083021";"";"None";"387.49";"0";"3.90";"372";"Cc1cc2c(c(C3CC3)n1)CN(c1cccc([C@H](C)Cc3nncn3C)c1)C2=O";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"16.83";"0.31";"2.62";"10.20";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5072916";"";"None";"499.54";"0";"3.91";"394";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc(CN4CC[C@H](O)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5070069";"";"None";"498.43";"1";"5.02";"446";"CC(O)c1cc2c(c(C(F)(F)F)c1)CN(c1cccc([C@@](C)(F)C(F)(F)c3nncn3C)c1)C2=O";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5085120";"";"None";"553.51";"1";"4.80";"452";"COC1CN(Cc2cc3c(c(C(F)(F)F)c2)CN(c2cccc([C@@](C)(F)C(F)(F)c4nncn4C)c2)C3=O)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088585";"";"None";"573.49";"2";"5.46";"461";"Cn1cnnc1C(F)(F)[C@](C)(F)c1cccc(N2Cc3c(cc(CN4C[C@@H](F)[C@@H](F)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080144";"";"None";"454.37";"0";"4.88";"471a";"Cn1cnnc1C[C@H](c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1)C(F)(F)F";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"15.41";"0.30";"2.12";"13.72";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089312";"";"None";"474.49";"0";"3.53";"365";"C[C@H](Cc1nncn1C)c1cc(N[C@@H](C)CO)nc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"14.75";"0.28";"3.47";"7.28";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083931";"";"None";"474.49";"0";"3.53";"366";"C[C@H](CO)Nc1cc([C@H](C)Cc2nncn2C)cc(N2Cc3c(cccc3C(F)(F)F)C2=O)n1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"14.75";"0.28";"3.47";"7.28";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088667";"";"None";"573.49";"2";"5.67";"453";"Cn1cnnc1C(F)(F)[C@](C)(F)c1cccc(N2Cc3c(cc(CN4CC(C(F)F)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093144";"";"None";"389.48";"0";"4.47";"9a";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2ccc3ccccc3n2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"16.74";"0.32";"2.05";"8.97";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5071228";"";"None";"387.90";"0";"4.28";"39";"Cc1nc(C(=O)Nc2cccc([C@H](C)Sc3nncn3C)c2)ccc1Cl";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"18.05";"0.37";"2.72";"9.63";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088493";"";"None";"404.50";"0";"4.31";"44";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cccc(-c3ccn[nH]3)c2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"13.65";"0.26";"1.21";"6.24";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5092989";"";"None";"408.41";"0";"3.73";"75";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2ccnc(C(F)(F)F)n2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"15.97";"0.32";"2.79";"7.62";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091801";"";"None";"409.52";"0";"4.20";"93";"COc1ccc(C(=O)Nc2cccc([C@H](C)Sc3nncn3C)c2)nc1C1CC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093390";"";"None";"425.41";"0";"4.47";"95";"CC(Sc1nncn1C)c1ccc(F)c(NC(=O)c2cccc(C(F)(F)F)n2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"14.10";"0.28";"1.53";"8.25";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5074787";"";"None";"368.47";"0";"3.27";"123";"CCc1cccc(C(=O)Nc2cc([C@H](C)Sc3nncn3C)ccn2)n1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"16.28";"0.32";"2.73";"7.01";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079056";"";"None";"493.52";"0";"3.30";"126";"C[C@H](Sc1nncn1C)c1ccnc(NC(=O)c2cc(N3CC[C@H](O)C3)cc(C(F)(F)F)n2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"12.16";"0.24";"2.70";"5.50";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091555";"";"None";"436.43";"0";"4.99";"168a";"C[C@H](Sc1nncn1C)c1cc(F)cc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"16.04";"0.32";"2.01";"13.72";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080052";"";"None";"437.45";"0";"3.70";"181";"Cn1cnnc1SC(CCO)c1cccc(NC(=O)c2cccc(C(F)(F)F)n2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"13.71";"0.27";"2.30";"6.46";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080363";"";"None";"513.52";"1";"3.34";"567";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(N5CCOCC5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091675";"";"None";"514.63";"1";"2.53";"573";"CN1CC2CCC(C1)N2c1cc(C(=O)Nc2cccc(C3(Cc4nncn4C)COC3)c2)nc(C2CC2)n1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5085393";"";"None";"561.56";"1";"4.74";"633";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCC(F)(F)CC5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083631";"";"None";"551.61";"1";"4.88";"641";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCC6(CC5)CC6)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5081344";"";"None";"577.58";"2";"5.16";"653";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5Cc6cccc(F)c6C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5085810";"";"None";"567.61";"1";"4.12";"708";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CC[C@@H]6OCC[C@@H]6C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5092976";"";"None";"581.64";"1";"4.51";"719";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCOC(C6CCC6)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5075412";"";"None";"569.60";"2";"5.52";"516";"C[C@H](c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3([C@H](F)c4nncn4C)COC3)c1)C2=O)N1CCC2(CC2)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5070030";"";"None";"502.59";"1";"3.30";"578";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CC[C@H](F)C5)nc4C4CC4)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083923";"";"None";"446.51";"0";"1.87";"234";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3C[C@@H]4[C@@H](O)[C@@H]4C3)ccn2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"13.44";"0.25";"4.13";"5.30";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083180";"";"None";"569.53";"2";"6.08";"460";"C[C@@H](c1cc2c(c(C(F)(F)F)c1)CN(c1cccc([C@@](C)(F)C(F)(F)c3nncn3C)c1)C2=O)N1CC[C@H](F)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5090719";"";"None";"387.90";"0";"4.28";"34";"Cc1cc(C(=O)Nc2cccc([C@H](C)Sc3nncn3C)c2)ncc1Cl";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"16.81";"0.34";"2.24";"8.97";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082421";"";"None";"353.45";"0";"3.50";"58";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cccc(N)c2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"15.63";"0.30";"2.02";"6.43";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076316";"";"None";"553.59";"1";"3.57";"531";"CN1CCC(=O)C(Cc2cc3c(c(C(F)(F)F)c2)CN(c2cccc(C4(Cc5nncn5C)COC4)c2)C3=O)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5090654";"";"None";"569.60";"1";"4.97";"557";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5[C@@H]6CC[C@H]5C[C@H](F)C6)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080084";"";"None";"394.50";"0";"3.90";"113";"Cc1ccc(C(=O)Nc2cc([C@H](C)Sc3nncn3C)ccn2)nc1C1CC1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"16.53";"0.32";"2.62";"7.62";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5090951";"";"None";"400.40";"1";"5.51";"268";"Cc1conc1CC(C)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"16.29";"0.31";"1.01";"14.07";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083340";"";"None";"463.52";"0";"3.93";"308";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc3ccc(OCC(=O)O)cc3cn2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"12.94";"0.25";"2.07";"5.03";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5090819";"";"None";"522.53";"1";"4.51";"385";"Cc1n[nH]c(C)c1-c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093119";"";"None";"434.45";"0";"3.82";"175";"CC(Sc1nncn1C)c1cc(N)nc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"12.71";"0.25";"1.70";"6.14";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5076323";"";"None";"428.42";"0";"4.31";"196";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2nc3c(C(F)(F)F)cccc3[nH]2)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091021";"";"None";"448.53";"0";"2.40";"223";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3C[C@@H](O)C[C@@H]3C)ccn2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"12.31";"0.23";"3.12";"4.88";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078511";"";"None";"399.42";"1";"5.24";"270a";"Cc1c[nH]nc1C[C@H](C)c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"16.33";"0.31";"1.28";"13.31";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086377";"";"None";"485.57";"0";"4.77";"307";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2cc3cc(OCc4ccn[nH]4)ccc3cn2)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"14.42";"0.27";"2.23";"6.33";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086154";"";"None";"376.46";"0";"4.56";"330";"Cc1cc(C(=O)Nc2cccc([C@H](C)Cc3nocc3C)c2)nc(C2CC2)n1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5087032";"";"None";"482.39";"0";"4.94";"345";"Cn1cnnc1C(F)(F)[C@](C)(F)c1cccc(NC(=O)c2nc3c(C(F)(F)F)cccc3[nH]2)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"14.51";"0.28";"2.06";"7.91";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078053";"";"None";"570.51";"1";"4.72";"549";"CN(c1cc2c(c(C(F)(F)F)c1)CN(c1cccc([C@@](C)(F)C(F)(F)c3nncn3C)c1)C2=O)[C@H]1CNC[C@H]1F";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"12.27";"0.24";"2.28";"10.56";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089187";"";"None";"515.63";"1";"4.30";"552";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCC(F)CC5)cc4C4CC4)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089042";"";"None";"513.48";"1";"3.46";"561";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(N5CCOC5=O)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089871";"";"None";"559.54";"1";"4.74";"602";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(N5CC6(C5)CC(F)(F)C6)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088137";"";"None";"577.55";"1";"3.97";"630";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCOC(C(F)F)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5092387";"";"None";"555.60";"1";"4.12";"632";"COC1CCN(Cc2cc3c(c(C(F)(F)F)c2)CN(c2cccc(C4(Cc5nncn5C)COC4)c2)C3=O)CC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5075078";"";"None";"575.58";"1";"4.98";"643";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCC(C(F)F)CC5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5085937";"";"None";"578.60";"1";"4.36";"649";"Cc1nc2c(o1)CCN(Cc1cc3c(c(C(F)(F)F)c1)CN(c1cccc(C4(Cc5nncn5C)COC4)c1)C3=O)C2";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5077749";"";"None";"463.52";"0";"3.93";"309";"C[C@H](Sc1nncn1C)c1cccc(NC(=O)c2ccc3c(OCC(=O)O)cccc3n2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"12.94";"0.25";"2.07";"5.03";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5094045";"";"None";"513.56";"1";"4.30";"398";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc(CN4CC[C@](C)(O)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5087227";"";"None";"501.53";"1";"4.88";"399";"C[C@H](Cc1nncn1C)c1cccc(N2Cc3c(cc(CN4CC[C@H](F)C4)cc3C(F)(F)F)C2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086144";"";"None";"540.59";"1";"3.65";"390";"C[C@@H]1CN(C)CCN1c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086679";"";"None";"391.48";"0";"3.49";"288";"Cc1ccc(C(=O)Nc2cccc([C@H](C)[C@H](O)c3nncn3C)c2)nc1C1CC1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"14.11";"0.26";"2.03";"5.94";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5090773";"";"None";"413.91";"0";"3.69";"186";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C(C)(C)O)c(Cl)cn2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"15.76";"0.31";"2.83";"7.02";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078148";"";"None";"536.56";"1";"3.85";"425";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CC(C)(C#N)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5079280";"";"None";"575.61";"1";"2.74";"434";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCS(=O)(=O)CC5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5070153";"";"None";"458.44";"0";"3.00";"437";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CO)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091033";"";"None";"573.59";"1";"4.45";"468";"CCOc1cc(N2Cc3c(cc(CN4CC[C@H](F)C4)cc3C(F)(F)F)C2=O)cc(C2(Cc3nncn3C)COC2)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082412";"";"None";"418.50";"0";"2.94";"534a";"Cc1cc(C(=O)Nc2cccc([C@]3(Cc4nncn4C)CCOC3)c2)nc(C2CC2)n1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"16.73";"0.31";"4.06";"7.38";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093761";"";"None";"552.60";"1";"3.79";"583";"CN1CCN(c2cc3c(c(C(F)(F)F)c2)CN(c2cccc(C4(Cc5nncn5C)COC4)c2)C3=O)CC12CC2";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5092484";"";"None";"434.50";"0";"1.87";"232";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2cc(C(=O)N3CC(CO)C3)ccn2)c1";"IC50";"'='";"1001.0";"nM";"6.00";"";"";"UO_0000065";"13.81";"0.26";"4.13";"5.30";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5094453";"";"None";"551.61";"1";"4.88";"517b";"Cn1cnnc1C[C@]1(c2cccc(N3Cc4c(cc(CN5CCC6(CC6)C5)cc4C(F)(F)F)C3=O)c2)CCOC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5069647";"";"None";"465.47";"1";"5.97";"116";"C[C@H](Sc1nncn1C)c1ccnc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)c1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"11.86";"0.25";"-0.45";"7.60";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093365";"";"None";"523.56";"1";"4.10";"487";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CC6(CC6)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5092169";"";"None";"559.54";"1";"4.20";"488";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CC6C(C5)C6(F)F)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091046";"";"None";"537.59";"1";"4.35";"491";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CC6CC6(C)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5081360";"";"None";"423.42";"0";"3.05";"495";"Cn1cnnc1CC1(c2cccc(NC(=O)c3nc(C(F)(F)F)cs3)c2)COC1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"15.40";"0.31";"3.47";"7.96";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5084849";"";"None";"489.58";"0";"2.98";"507";"Cc1conc1CC1(c2cccc(NC(=O)c3cc(CN4CC[C@H](O)C4)nc(C4CC4)n3)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5072017";"";"None";"565.60";"1";"4.67";"525";"C[C@@H]1CN(Cc2cc3c(c(C(F)(F)F)c2)CN(c2cccc(-c4c(-c5nncn5C)cnn4C)c2)C3=O)C[C@H](C)O1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5078240";"";"None";"512.53";"1";"4.23";"529";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CC5CCCO5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5074610";"";"None";"564.53";"1";"4.86";"563";"CN1C[C@H]2C[C@@H]1CN2c1cc2c(c(C(F)(F)F)c1)CN(c1cccc([C@@](C)(F)C(F)(F)c3nncn3C)c1)C2=O";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089392";"";"None";"579.54";"2";"5.16";"571";"C[C@H](c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3(C(F)(F)c4nncn4C)COC3)c1)C2=O)N1CC[C@H](F)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086148";"";"None";"569.60";"2";"5.52";"576";"C[C@H](c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3([C@@H](F)c4nncn4C)COC3)c1)C2=O)N1CCC2(CC2)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5092935";"";"None";"513.65";"1";"3.79";"592a";"C[C@@H](c1cc(C(=O)Nc2cccc(C3(Cc4nncn4C)COC3)c2)nc(C2CC2)n1)N1CCC2(CC2)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5090771";"";"None";"547.53";"1";"4.60";"601";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(N5CCC(C(F)F)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5077298";"";"None";"498.51";"0";"4.01";"613";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(C5CCOC5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080902";"";"None";"436.38";"0";"4.59";"617";"Cn1cnnc1C[C@H](c1cccc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1)C(F)F";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"16.04";"0.31";"2.41";"13.72";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5072032";"";"None";"550.59";"1";"4.24";"628";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCC(C#N)CC5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5090260";"";"None";"575.58";"1";"4.98";"635";"CC1CCN(Cc2cc3c(c(C(F)(F)F)c2)CN(c2cccc(C4(Cc5nncn5C)COC4)c2)C3=O)CC1(F)F";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5073261";"";"None";"573.57";"1";"4.59";"640";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CC6CC(C5)C6(F)F)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082077";"";"None";"573.62";"2";"5.06";"650";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCc6ccccc6C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5092399";"";"None";"577.58";"2";"5.16";"655";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5Cc6ccc(F)cc6C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5094038";"";"None";"594.04";"2";"5.67";"657";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5Cc6cccc(Cl)c6C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088501";"";"None";"584.60";"1";"4.89";"658";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5Cc6cccc(C#N)c6C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5074467";"";"None";"569.60";"2";"5.49";"675b";"Cn1cnnc1[C@H](F)C1(c2cccc(N3Cc4c(cc(CN5C6CCCC5CC6)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5094662";"";"None";"579.54";"2";"5.16";"678";"CC(c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3(C(F)(F)c4nncn4C)COC3)c1)C2=O)N1CC[C@H](F)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5080596";"";"None";"471.48";"0";"4.24";"687";"C[C@H](Cc1nncn1C)c1cc(C2CCOC2)nc(N2Cc3c(cccc3C(F)(F)F)C2=O)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"13.83";"0.26";"2.28";"8.92";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5088409";"";"None";"551.61";"2";"5.05";"701";"CC(c1nncn1C)C1(c2cccc(N3Cc4c(cc(CN5CCC6(CC6)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"11.82";"0.22";"1.47";"10.27";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5092840";"";"None";"571.60";"1";"3.09";"717";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCOC(CCO)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5092178";"";"None";"543.57";"1";"4.44";"489";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCC(F)CC5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082917";"";"None";"537.59";"1";"4.49";"490";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCCC6CC65)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5083553";"";"None";"395.49";"0";"2.91";"494";"Cn1cnnc1CC1(c2cccc(NC(=O)c3csc(C4CC4)n3)c2)COC1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"17.70";"0.34";"4.09";"8.54";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5091337";"";"None";"484.60";"0";"3.44";"497";"Cn1cnnc1CC1(c2cccc(NC(=O)c3cc(CN4CCC5CC54)cc(C4CC4)n3)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5087648";"";"None";"537.59";"1";"4.49";"520";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CCC6(CC6)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5071760";"";"None";"462.42";"0";"4.90";"527";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cccc4C(F)(F)F)C3=O)c2)CC(F)(F)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5090280";"";"None";"543.57";"1";"4.61";"543a";"C[C@@H](c1cc2c(c(C(F)(F)F)c1)CN(c1cccc(C3(Cc4nncn4C)COC3)c1)C2=O)N1CC(C)(F)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5092415";"";"None";"535.57";"1";"4.57";"559";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(C5=CN6CCC5CC6)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"13.07";"0.25";"2.43";"11.03";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093831";"";"None";"579.54";"2";"5.20";"581";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(C(N5CCCC5)C(F)(F)F)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5093367";"";"None";"559.54";"1";"4.74";"603";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(N5CC6(CCC6(F)F)C5)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5084524";"";"None";"539.56";"1";"3.48";"619";"Cn1cnnc1CC1(c2cccc(N3Cc4c(cc(CN5CC6CC5CO6)cc4C(F)(F)F)C3=O)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5082950";"";"None";"519.50";"1";"2.93";"699";"Cn1cnnc1CC1(c2cccc(NC(=O)c3cc(CN4CC[C@H](F)C4)nc(C(F)(F)F)n3)c2)COC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5086448";"";"None";"418.50";"0";"3.04";"705";"CCn1cnnc1CC1(c2cccc(NC(=O)c3cc(C)nc(C4CC4)n3)c2)COC1";"IC50";"'='";"3001.0";"nM";"5.52";"";"";"UO_0000065";"13.20";"0.24";"2.48";"5.82";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5089546";"";"None";"361.41";"0";"2.46";"316";"C[C@H](Cc1nncn1C)c1cccc(NC(=O)c2ccn3nccc3n2)c1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"18.04";"0.33";"4.06";"7.25";"0";"CHEMBL5051161";"Inhibition of N-terminal Avi-tagged human CBL-B (36 to 427 residues) incubated with 60 nM Src kinase for 1.5 hrs followed by incubation with fluorescently labeled UbcH5B-Ub for 1 hr and measured by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4879459";"E3 ubiquitin-protein ligase CBL-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050844";"38";"Patent Bioactivity Data";"";"2019";"None";"Dose = 60.0 nM | TIME = 1.5 hr";"INHIBITOR";""
